Document:

Exhibit 10.15

 

Execution
Version

 

AMENDED
AND RESTATED

SHAREHOLDERS’ AGREEMENT

 

TRIAGE
TECHNOLOGIES INC.

 

 

March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     

     

    

 

TABLE
OF CONTENTS

 

	ARTICLE 1 
	 	INTERPRETATION	 
	 	 	 
	1.1	Definitions	2
	1.2	Additional Definitions	6
	1.3	Sections and Headings	6
	1.4	Rules of Construction	6
	1.5	Governing Law and Submission to Jurisdiction	7
	1.6	Severability	7
	1.7	No Waiver	7
	 	 	 
	ARTICLE 2

	 	PURPOSE AND SCOPE	 
	 	 	 
	2.1	Compliance with Agreement	8
	2.2	Conflict with Articles or By-laws	8
	2.3	Change in Shares	8
	2.4	Additional Shares	8
	2.5	Covenants of Principals	8
	2.6	Ceasing to be a Party	9
	2.7	Unanimous Shareholders’ Agreement	9
	2.8	Schedules	9
	 	 	 
	ARTICLE 3 
	 	CORPORATE GOVERNANCE	 
	 	 	 
	3.1	Board of Directors	9
	3.2	Shareholder Matters	10
	3.3	Information Rights	11
	 	 	 
	ARTICLE 4

	 	RESTRICTIONS ON TRANSFER	 
	 	 	 
	4.1	Restrictions on Transfer	11
	4.2	Transfers to Eligible Transferees	11
	4.3	Certificates and Legend	12
	4.4	Corporation to Enforce	12
	4.5	Certain Transfers Ineffective	12
	 	 	 
	ARTICLE 5 
	 	DRAG-ALONG RIGHTS	 
	 	 	 
	5.1	Actions to be Taken	13
	5.2	Conditions	14
	 	 	 
	ARTICLE 6
	TAG-ALONG RIGHTS
	 
	6.1	Tag-Along Offer	15
	6.2	Tag-Along Acceptance	15

 

    -i-

     

    

 

	ARTICLE 7

	 	CLOSING PROCEDURES	 
	 	 	 
	7.1	Time and Place of Closing	16
	7.2	Governmental Approvals	17
	 	 	 
	ARTICLE 8
	CONFIDENTIALITY AND ADDITIONAL COVENANTS
	 	 	 
	8.1	Confidentiality	17
	8.2	Equitable Remedies	18
	8.3	Non-Solicitation	18
	8.4	Non-Disparagement	18
	8.5	Non-Merger	19
	 	 	 
	ARTICLE 9 
	 	AMENDMENT AND TERMINATION	 
	 	 	 
	9.1	Amendments	19
	9.2	Term and Termination Events	19
	9.3	Surviving Obligations	19
	 	 	 
	ARTICLE 10 
	 	MISCELLANEOUS	 
	 	 	 
	10.1	Notices	20
	10.2	Management Shareholder Power of Attorney	20
	10.3	Amendment and Restatement	21
	10.4	Enurement	21
	10.5	Entire Agreement	21
	10.6	Independent Legal Advice	21
	10.7	Assignment	21
	10.8	No Third-party Beneficiaries	21
	10.9	Counterparts	21

 

    -ii-

     

    

 

TRIAGE TECHNOLOGIES INC.

 

AMENDED AND RESTATED

SHAREHOLDERS’ AGREEMENT

 

THIS AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT made this
31st day of March, 2021, B E T W E E N:

 

TRIAGE TECHNOLOGIES INC.,

a corporation existing under the federal laws of Canada,

 

(hereinafter referred to as the “Corporation”),

 

-and-

 

The shareholders of the Corporation as set out on the signature pages
hereto, and such additional holders of Shares who subsequently become parties to this Agreement by signing a Counterpart,

 

(hereinafter referred to, collectively, as the “Shareholders”
and, individually, as a “Shareholder”),

 

-and-

 

The Principals as set out on the signature pages hereto.

 

WHEREAS the authorized share capital of the Corporation
consists of an unlimited number of Series A common shares (the “Series A Commons”), an unlimited number of Series B
common shares (the “Series B Commons”) and an unlimited number of Series C common shares (the “Series C Commons”);

 

AND WHEREAS the Corporation and its shareholders
are party to a shareholders’ agreement dated April 5, 2016 (the “Original Shareholders’ Agreement”);

 

AND WHEREAS the Corporation and its shareholders wish to amend and
restate the Original Shareholders’ Agreement on the terms and conditions set forth in this Agreement;

 

AND WHEREAS the parties wish to establish their
respective rights and obligations in respect of the management and control of the Corporation and in respect of certain other matters
set forth in this Agreement;

 

NOW THEREFORE THIS AGREEMENT WITNESSES THAT in
consideration of the respective covenants, representations and warranties herein contained and for other good and valuable consideration,
the receipt and sufficiency of all of which are acknowledged by each of the parties, the parties covenant and agree as follows:

 

     

     

    

 

ARTICLE 1 INTERPRETATION

 

		1.1	Definitions

 

For the purposes of this Agreement, the following
terms shall have the respective meanings set out below and grammatical variations of such terms shall have corresponding meanings:

 

“Act” means the Canada Business Corporations
Act;

 

“Affiliate” has the meaning set out in the Act;

 

“Articles” means the articles of incorporation
of the Corporation, as the same may be amended or replaced from time to time in accordance with the Act;

 

“ASPE” means Canadian Accounting Standards For Private
Enterprises;

 

“Asset Sale” means a sale, lease or other disposition
of all or substantially all of the assets of the Corporation and its subsidiaries taken as a whole by means of any transaction or series
of related transactions, except where such sale, lease or other disposition is to an Affiliate of the Corporation;

 

“Board” means the board of directors of the Corporation
or, if applicable, any committee of Directors to which the board of directors of the Corporation may delegate any of its powers, duties
or authority in accordance with the Act;

 

“Business Day” means any day other than a Saturday,
Sunday or a statutory holiday in the Province of Ontario on which commercial banks in Toronto, Ontario are open for business;

 

“Change of Control Transaction” means either (a)
a Share Sale; or (b) an Asset Sale;

 

“Common Shares” means, collectively, the Series
A Commons, the Series B Commons and the Series C Commons;

 

“control” means, in respect of any person, the following:

 

		(a)	in the case of a corporation,

 

		(i)	holding voting securities or having the power to vote voting securities carrying more than 50% of the votes for the election of directors;
and

 

		(ii)	the votes carried by such securities are entitled, if exercised, to elect a majority of the directors of the person;

 

		(b)	in the case of a limited liability company or partnership, other than a limited partnership, holding more than 50% of the equity interests
in the limited liability company or partnership; or

 

		(c)	in the case of a limited partnership, being the general partner;

 

    -2-

     

    

 

provided that “control” includes the possession,
directly or indirectly, of the power to control and direct the management and policies of such person, whether through ownership of voting
securities, by contract or otherwise;

 

“Corporation” means Triage Technologies Inc. and
includes any successor to the Corporation resulting from any reorganization, arrangement, amalgamation or merger, statutory or otherwise,
or from any continuance under the laws of another jurisdiction;

 

“Counterpart” means an agreement substantially in
the form attached hereto as Schedule A by which a person agrees to be bound by this Agreement as a Shareholder in accordance with the
provisions of this Agreement;

 

“CPOA” has the meaning set out in Section 10.2;

 

“Director” means a director of the Corporation;

 

“Drag-Along Notice” has the meaning set out in Section
5.1;

 

“Eligible Transferee” means, in respect of any particular
Shareholder:

 

		(a)	a Personal Entity of such Shareholder;

 

		(b)	in the case of a Shareholder that is a body corporate, any other body corporate that is an Affiliate of such Shareholder and any person
who is the controlling registered and beneficial shareholder or member of such body corporate or any Affiliate of such shareholder or
member;

 

		(c)	a Family Member of such Shareholder; and

 

		(d)	where the context permits, upon the death of the Shareholder, the beneficiary or beneficiaries of the estate of such Shareholder;

 

“Encumbrance” means any hypothec,
mortgage, charge, pledge, prior claim, security interest, assignment, lien (statutory or otherwise) or other encumbrance, arrangement
or condition of any nature which, in substance, secures payment or performance of an obligation;

 

“Family Member” means, in relation to an individual,
the parent, aunt, uncle, grandparent, sibling, niece, nephew or cousin (by birth, adoption or marriage) of such individual, the spouse
of such individual (and the spouse’s parent, aunt, uncle, grandparent, sibling, niece, nephew or cousin), and lineal descendants
(by birth, adoption or marriage) of such individual and/or of the spouse of such individual;

 

“Family Trust” means, in relation
to an individual, a trust (including a testamentary trust), the beneficiaries and potential beneficiaries of which do not include any
person other than the individual or his or her Family Members or a corporation or other entity all of the equity interests or other ownership
interests in which are, directly or indirectly, beneficially owned by, or for the benefit of, such individual or his or her Family Members,
and all of the voting interests of which are held by such individual or his or her Family Members or persons who are Personal Entities
of such individual, and the trustees of which are persons resident in Canada for purposes of the Income Tax Act (Canada);

 

    -3-

     

    

 

“Information” has the meaning set out in Section
8.1;

 

“IPO” means an initial public
offering of Shares by way of a prospectus, offering circular, registration statement or similar disclosure document where, or in connection
with which, such Shares are to become listed and posted for trading on a stock exchange in Canada or the United States, including by way
of a reverse take-over or similar transaction, in each case resulting in the Shares being freely tradeable in the jurisdiction to and
between members of the public without the requirement of filing a prospectus or similar disclosure document;

 

“Major Shareholder” means any Shareholder who,
together with its Affiliates, holds at least 15% of the issued and outstanding Shares (on a fully-diluted basis);

 

“Management Shareholder” means any Shareholder who
is, or whose Principal is, an employee or former employee of, or consultant or former consultant to, the Corporation or a subsidiary of
the Corporation and includes any Eligible Transferee of such Management Shareholder who becomes a party by executing a Counterpart;

 

“Other Shareholders” has the meaning set out in
Section 5.1;

 

“parties” means, collectively, the Corporation,
the Shareholders and the Principals, if any, and “party” means any one of them;

 

“person” includes any individual,
corporation, partnership, firm, joint venture, syndicate, limited liability company, association, trust, government, governmental agency
and any other form of entity or organization;

 

“Personal Entity” means a Family Trust, corporation
or limited liability company established by or for the benefit of a Shareholder, its Principal or his or her Family Members, all of the
equity interests in which are, if applicable, directly or indirectly, beneficially owned by, or for the benefit of, such Shareholder,
its Principal or his or her Family Members, the trustees of which are and all of the voting interests of which are, as applicable, held
by such Shareholder, its Principal or his or her Family Members or persons who are Personal Entities of the same individual;

 

“Principal” means, in relation to a Shareholder
and for each person that becomes a party to this Agreement at any time after the date hereof in accordance with the terms of this Agreement,
the individual who ultimately controls such person at such time;

 

“Proposed Sale” has the meaning set out in Section
5.2.

 

“Restriction Period” means,
(a) in respect of any Management Shareholder or its Principal, the period commencing on the date such person becomes a Shareholder and
ending on the date that is 12 months from the date that such person or its Principal ceased to be an employee of, or consultant to, the
Corporation or a subsidiary of the Corporation and (b) in respect of any other Shareholder or its Principal, the period commencing on
the date such person becomes a Shareholder and ending on the date that is 12 months from the date that such person ceased to be a Shareholder;

 

    -4-

     

    

 

“Securities” means all Shares
and all options, warrants, convertible instruments and other similar rights entitling the holder thereof to acquire any Shares, whether
or not upon the payment of additional consideration therefor;

 

“Selling Shareholders” has
the meaning set out in Section 5.1;

 

“Series A Commons” has the
meaning set out in the recitals to this Agreement;

 

“Series B Commons” has the meaning set out in the recitals to this
Agreement;

 

“Series C Commons” has the meaning set out in the recitals to this Agreement;

 

“Share Sale” means the acquisition of the Corporation
by another entity by means of any transaction or series of related transactions (including, without limitation, any share acquisition,
reorganization, merger, amalgamation, arrangement or consolidation but excluding any issuance of shares for capital raising purposes)
which results in a person or group of related persons holding more than 50% of the voting rights attaching to all issued and outstanding
Common Shares of the Corporation or such other surviving or continuing entity resulting from such transaction or series of transactions
(or if the Corporation or such other surviving or continuing entity is a wholly-owned subsidiary immediately following such acquisition,
its parent);

 

“Shareholder Majority” means,
at any time, one or more Shareholders holding not less than 50% of the voting rights attaching to all issued and outstanding Common Shares
at such time;

 

“Shareholder Super-Majority”
means, at any time, two or more Shareholders holding not less than 80% of the voting rights attaching to all issued and outstanding Common
Shares at such time;

 

“Shareholder Representative”
has the meaning set out in Section 5.1(f).

 

“Shareholders” and “Shareholder”
have the meanings set out in the parties section hereof;

 

“Shares” means the Common Shares and any other shares
in the equity capital of the Corporation that may be authorized after the date hereof in accordance with the Act;

 

“Tag-Along Acceptance” has
the meaning set out in Section 6.1;

 

“Tag-Along Offer” has the meaning
set out in Section 6.1;

 

“Third Party” means, in relation
to the Shareholders or any Shareholder (as the context may require), a person with whom all the Shareholders or any one such Shareholder,
as the case may be, and the Corporation deals at “arm’s length” (as such term is defined in the Income Tax Act
(Canada)), and excludes any Eligible Transferee;

 

“Third Party Offer” has the
meaning set out in Section 5.1;

 

“Third Party Purchaser” has
the meaning set out in Section 5.1;

 

“Transfer” means any disposition, transfer, sale,
exchange, assignment, gift, bequest, disposition, Encumbrance, or any arrangement by which possession, legal title or beneficial ownership
passes, directly or indirectly, from one person to another, or to the same person in a different capacity, whether or not voluntary and
whether or not for value, and includes any agreement to effect the foregoing; and

 

“Transferor” has the meaning set out in Section
4.2(a).

 

    -5-

     

    

 

		1.2	Additional Definitions

 

Unless there is something
inconsistent in the subject matter or context, or unless otherwise provided in this Agreement, all other words and terms used in this
Agreement that are defined in the Act have the meanings set out in the Act.

 

		1.3	Sections and Headings

 

The table of contents and the division of this
Agreement into Articles and Sections and the insertion of headings are for convenience of reference only and shall not affect the interpretation
of this Agreement. The terms “this Agreement”, “hereof”, “herein”, “hereunder” and similar
expressions refer to this Agreement and not to any particular Article, Section, Schedule or other portion hereof and include any agreement
or instrument supplementary or ancillary hereto. Unless otherwise specified, any reference to an Article, Section or Schedule refers to
the specific Article, Section or Schedule of this Agreement.

 

		1.4	Rules of Construction

 

In this Agreement:

 

		(a)	words importing the singular number only shall include the plural and vice versa and words importing the use of any gender shall include
all genders;

 

		(b)	the word “including” is deemed to mean “including without limitation”;

 

		(c)	all terms defined in this Agreement have the same defined meanings when used in any certificate or other document made or delivered
pursuant hereto, unless otherwise defined therein;

 

		(d)	references to any agreement or other instrument in writing means such agreement or instrument in writing,
as amended, modified, replaced or supplemented from time to time;

 

		(e)	any reference to a statute, regulation or rule shall be construed to be a reference thereto as the same may from time to time be amended,
re-enacted or replaced, and any reference to a statute shall include any regulations or rules made thereunder;

 

		(f)	unless otherwise specified, all dollar amounts refer to Canadian dollars;

 

		(g)	references to a particular number of Shares calculated on a “fully-diluted basis” means, at any relevant time, the
                                                               aggregate of all such issued and outstanding Shares and any such Shares that may be issued upon the exercise, conversion
or exchange of all outstanding Securities;

 

    -6-

     

    

 

		(h)	all accounting terms used herein and not expressly defined herein shall have the meanings given to them under ASPE;

 

		(i)	any time period within which a payment is to be made or any other action is to be taken hereunder shall be calculated excluding the
day on which the period commences and including the day on which the period ends; and

 

		(j)	whenever any payment is required to be made, action is required to be taken or period of time is to expire on a day other than a Business
Day, such payment shall be made, action shall be taken or period shall expire on the next following Business Day.

 

		1.5	Governing Law and Submission to Jurisdiction

 

(a) This
Agreement shall be interpreted and enforced in accordance with, and the respective rights and obligations of the parties shall be governed
by, the laws of the Province of Ontario and the federal laws of Canada applicable in that province.

 

(b) Each
of the parties irrevocably and unconditionally (i) submits to the non- exclusive jurisdiction of the courts of the Province of Ontario
over any action or proceeding arising out of or relating to this Agreement, (ii) waives any objection that it might otherwise be entitled
to assert to the jurisdiction of such courts and (iii) agrees not to assert that such courts are not a convenient forum for the determination
of any such action or proceeding.

 

		1.6	Severability

 

If any provision of this Agreement is determined
by a court of competent jurisdiction to be invalid, illegal or unenforceable in any respect, all other provisions of this Agreement shall
nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not
affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid, illegal or
incapable of being enforced, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of
the parties as closely as possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent
possible.

 

		1.7	No Waiver

 

The failure of any party to insist upon strict
adherence to any provision of this Agreement on any occasion shall not be considered a waiver or deprive that party of the right thereafter
to insist upon strict adherence to such provision or any other provision of this Agreement. No purported waiver shall be effective as
against any party unless consented to in writing by such party. The waiver by any party of a breach of any provision of this Agreement
shall not operate or be construed as a waiver of any subsequent or other breach.

 

    -7-

     

    

 

ARTICLE 2

PURPOSE
AND SCOPE

 

		2.1	Compliance with Agreement

 

Each Shareholder agrees to execute and
deliver all such documents, to exercise all voting rights attaching to any Shares held by him, her or it and to do all such other
acts and things as the Corporation or any other Shareholder, acting reasonably, may consider necessary or advisable from time to
time to give full effect to the provisions and intent of this Agreement and to ensure that the provisions of this Agreement shall
govern the affairs of the Corporation to the fullest extent permitted by law (including to amend or waive any provision contained in
the Articles or by-laws to the extent inconsistent with the provisions and intent of this Agreement). By its execution of this
Agreement, the Corporation acknowledges that it has actual notice of the terms hereof and agrees with each of the Shareholders that,
to the fullest extent permitted by law, it will do all things necessary to comply with, and give effect fully to, the provisions and
intent of this Agreement.

 

		2.2	Conflict with Articles or By-laws

 

To the extent permitted by the Act, in the event
of any conflict between the provisions of this Agreement and the provisions of the Articles or by-laws of the Corporation, the provisions
of this Agreement shall prevail, and, if necessary or appropriate, upon request by the Corporation, the Shareholders shall vote to amend
the Articles and/or by-laws of the Corporation so as to ensure conformity with the terms of this Agreement.

 

		2.3	Change in Shares

 

The provisions of this Agreement relating to
Shares shall apply, with necessary modifications, to:

 

		(a)	any securities into which such Shares may be converted, reclassified, redesignated, subdivided, consolidated or otherwise changed
from time to time;

 

		(b)	any securities received as a dividend or distribution on or in respect of any Shares; and

 

		(c)	any securities of any successor to the Corporation that may be received in respect of any Shares on a reorganization, recapitalization,
arrangement, amalgamation or merger, statutory or otherwise.

 

		2.4	Additional Shares

 

Each Shareholder agrees that all Shares hereafter
acquired by such Shareholder shall be subject in all respects to the provisions of this Agreement.

 

		2.5	Covenants of Principals

 

Each Principal hereby agrees to take any
such actions as may be necessary to cause the Shareholder which he or she controls to, at all times, fully and faithfully perform
and discharge its obligations under this Agreement and comply in all respects with the terms and conditions of this Agreement. The
foregoing covenants and obligations of the Principals are absolute, unconditional, present and continuing and are in no way
conditional or contingent upon any event or circumstance, action or omission which might in any way discharge a guarantor or
surety.

 

    -8-

     

    

 

		2.6	Ceasing to be a Party

 

Except as otherwise specifically provided herein,
if a person who was a Shareholder no longer holds any Shares, then from that point forward that person shall be deemed to no longer be
a party to this Agreement and shall have no further rights or obligations under this Agreement, other than any rights or obligations arising
before such Shareholder ceased to be a party.

 

		2.7	Unanimous Shareholders’ Agreement

 

This Agreement is intended by the parties to
constitute a unanimous shareholders’ agreement for purposes of the Act.

 

		2.8	Schedules

 

Schedule A-Form of Counterpart

 

ARTICLE 3 CORPORATE GOVERNANCE

 

		3.1	Board of Directors

 

(a) The
Board shall consist of such number of Directors as the Shareholders or, subject to the Act, the Directors may from time to time determine.
As of the date hereof, the Board shall consist of two Directors, being Tory Jarmain and Eric Lau.

 

(b) Except
as may otherwise be provided in this Agreement, all decisions of the Board and any committees of the Board shall be decided by a majority
of votes cast at the applicable meeting, or, with respect to any decision made by the Board, by written resolution signed by all of the
Directors.

 

(c) The
Board shall meet at least once in every calendar quarter and more often as circumstances require in Toronto, Ontario or any other place
as the Directors may determine from time to time. Meetings of the Directors may be called by any Director upon not less than 20 days’
notice, which notice shall contain a summary of the business proposed to be transacted at such meeting, a reasonable description of each
item of business and copies of the documents or other materials to be considered at the meeting. A Director may, by an instrument in writing
delivered before or after the meeting or by participating in the meeting, waive notice of any meeting of the Board, in which event any
such meeting, insofar as such Director is concerned, shall be considered to be duly constituted notwithstanding the absence of notice
in respect thereof.

 

    -9-

     

    

 

(d) No resolution or other matter shall be
voted on, or approved at, any meeting of the Board unless a majority of the Directors then in office is present (in person or by
conference call) at the meeting; provided, however, that (i) if no such quorum is present within half an hour following the time at
which the meeting is scheduled to take place, the meeting shall stand adjourned to the same day in the immediately following week
(or, if that day is not a Business Day, the next following Business Day) at the same time and place and (ii) if no such quorum is
present within one hour following the time at which the adjourned meeting is scheduled to take place, the Directors present at the
adjourned meeting shall constitute a quorum for the transaction of the business for which the meeting was called if permitted by the
Act, failing which the meeting shall again stand adjourned and be rescheduled in accordance with this Section 3.1(d). Directors may
attend meetings of the Board from time to time by telephone or any other means of electronic communication that permits all
Directors present in person or otherwise participating at the meeting to communicate with each other.

 

(e) The
Directors shall serve as such without remuneration. The Corporation shall reimburse the Directors for all reasonable out-of-pocket costs
and expenses incurred by them in connection with their attendance at any meetings of the Board, in accordance with such reimbursement
policies as may be established or approved from time to time by the Board.

 

(f) The
Corporation shall maintain directors’ and officers’ liability insurance in an amount and on terms and conditions satisfactory
to the Board and shall use commercially reasonable efforts to cause such insurance to be maintained until such time as the Board may determine.

 

		3.2	Shareholder Matters

 

(a) Meetings
of Shareholders shall be held in Toronto, Ontario or any other place as the Directors may determine from time to time. Notice of the time
and place of any meetings of the Shareholders shall be delivered by email to the Shareholders entitled to vote thereon at their email
address for notice, not less than 10 days before the meeting. Such notice can be waived in writing by any of the Shareholders either before
or after the meeting. The attendance of a Shareholder at a meeting shall constitute a waiver of notice of such meeting except where such
person attends a meeting for the express purpose of objecting to the transaction of any business on the grounds that the meeting has not
been lawfully called or convened.

 

(b) No
resolution shall be considered or voted on, and no other business shall be conducted at, any meeting of the Shareholders unless not fewer
than two persons constituting a Shareholder Majority are present at the meeting; provided, however, that (A) if no such quorum is present
within half an hour following the time at which the meeting is scheduled to take place, the meeting shall stand adjourned to the same
day in the immediately following week (or, if that day is not a Business Day, the next following Business Day) at the same time and place
and (B) if no such quorum is present within half an hour following the time at which the adjourned meeting is scheduled to take place,
the meeting shall again stand adjourned and be rescheduled in accordance with Section 3.2(a).

 

(c) The
chair of a meeting of Shareholders shall be, if present, the Chief Executive Officer of the Corporation, and, if not present, shall be
an individual designated by the Shareholder Majority. If the chair is not present within 20 minutes after the time fixed for the holding
of any meeting or if the chair is unable or unwilling to act in such capacity, the Shareholders present at the meeting shall appoint an
individual to act as chair of such meeting. Notwithstanding any statutory rule or rule of procedure to the contrary, the chair at such
meeting shall not be entitled to a second, extra or casting vote in the case of a tie vote at any such meeting.

 

    -10-

     

    

 

		3.3	Information Rights

 

(a) Within
90 days following the end of each financial year of the Corporation, the Corporation shall deliver to the Major Shareholders unaudited
financial statements of the Corporation in respect of such financial year prepared in accordance with ASPE.

 

(b) The
Corporation shall supply on a timely basis all necessary financial and other information to the Shareholders as of the end of their respective
fiscal and/or tax accounting years in order to permit each Shareholder to comply on a timely basis with its respective reporting and tax
requirements.

 

ARTICLE 4

RESTRICTIONS ON TRANSFER

 

		4.1	Restrictions on Transfer

 

Except as specifically provided for in this Agreement,
no Shareholder shall Transfer any of his, her or its right, title or interest in or to any Securities now or hereafter owned of record
or beneficially by him, her or it without the express prior written consent of the Board and provided further that any such transferee
shall agree to be bound by the terms hereof by executing a Counterpart.

 

		4.2	Transfers to Eligible Transferees

 

(a) Notwithstanding
Section 4.1, a Shareholder (the “Transferor”) may at any time or from time to time Transfer all or a portion of his,
her or its Securities to an Eligible Transferee of such Transferor provided that, at or prior to the time of such Transfer:

 

		(i)	such Eligible Transferee shall execute a Counterpart; and

 

		(ii)	the Board receives evidence satisfactory to it, acting reasonably, that such Eligible Transferee is an Eligible Transferee of the
Transferor and that the Counterpart referred to in Section 4.2(a)(i) is a legal, valid and binding obligation of the Eligible Transferee,

 

provided that, notwithstanding the foregoing, no Shareholder shall,
without the prior written consent of the Board, Transfer any Securities to any Eligible Transferee if such Eligible Transferee (in the
reasonable determination of the Board) competes with the Corporation and/or any of its subsidiaries.

 

 (b) Notwithstanding anything to the contrary in this Agreement,

 

		(i)	the Transferor shall at all times after the transfer of Securities to the Eligible Transferee be jointly and severally liable with
such Eligible Transferee for the observance and performance of the covenants and obligations of the Eligible Transferee under this Agreement,
shall cause the Eligible Transferee to remain an Eligible Transferee of the Transferor so long as the Eligible Transferee shall have any
registered or beneficial interest in the Securities, and the Transferor and Eligible Transferee shall jointly and severally indemnify
the other parties hereto against any loss, damage or expense incurred as a result of the failure by the Eligible
Transferee to comply with the provisions of this Agreement; and

 

    -11-

     

    

 

		(ii)	if a Transferor transfers less than all of his, her or its Securities to an Eligible Transferee, such Transferor and Eligible Transferee
shall for the purposes of this Agreement act (through the Transferor only) as a single Shareholder and shall benefit from and exercise
all of their rights and obligations under this Agreement as one entity. Without limiting the generality of the foregoing, the exercise
of any right, including the right to vote Shares, the giving of any notice, the sending of any document to and the service of any procedure
by or upon such Transferor shall be deemed to have been simultaneously exercised, sent to or served by or upon such Eligible Transferee,
and vice versa.

 

		4.3	Certificates and Legend

 

(a) Each
Shareholder acknowledges and agrees that, unless the Board determines otherwise: (i) all Shares held by such Shareholder shall be in uncertificated
form; (ii) such Shareholder will only be entitled to a non-transferable written acknowledgement contemplated in Section 49(1) of the Act;
and (iii) such Shareholder shall refrain from requesting that any certificates representing such Shares be issued.

 

(b) All
certificates (if the Board determines after the date hereof to issue certificates), and all non-transferable written acknowledgements
delivered pursuant to Section 49(1) of the Act in respect of uncertificated shares, representing Shares now or hereafter held by a Shareholder
shall have the following legend noted conspicuously on such certificate or notice, in addition to any other legends that may imposed pursuant
to applicable laws:

 

“THE SECURITIES REPRESENTED BY THIS [CERTIFICATE/NOTICE] ARE
SUBJECT TO THE PROVISIONS OF AN AMENDED AND RESTATED UNANIMOUS SHAREHOLDERS’ AGREEMENT MADE AS OF THE 31ST DAY OF MARCH, 2021, WHICH
CONTAINS RESTRICTIONS ON THE RIGHT TO TRANSFER, PLEDGE, VOTE AND OTHERWISE DEAL WITH SUCH SECURITIES, A COPY OF WHICH AGREEMENT IS AVAILABLE
FOR INSPECTION FROM THE CORPORATION. NOTICE OF SUCH RESTRICTIONS AND THE OTHER PROVISIONS OF SUCH AGREEMENT IS HEREBY GIVEN.”

 

		4.4	Corporation to Enforce

 

The Corporation shall not accept for registration
in its relevant books of record any Transfer of Securities not made in accordance with the provisions of this Agreement.

 

		4.5	Certain Transfers Ineffective

 

Any Transfer of Securities attempted to be made
other than in accordance with the provisions of this Agreement shall be void and of no effect.

 

    -12-

     

    

 

ARTICLE 5

DRAG-ALONG
RIGHTS

 

		5.1	Actions to be Taken

 

If Shareholders constituting a Shareholder Majority
(the “Selling Shareholders”) receive and wish to accept a bona fide offer in writing from a Third Party (the
“Third Party Purchaser”) to purchase all, but not less than all, of the Shares held by the Selling Shareholders, which,
if consummated, would constitute a Change of Control Transaction (a “Third Party Offer”), then the Selling Shareholders
may deliver written notice (a “Drag-Along Notice”) to the other Shareholders (the “Other Shareholders”)
and the Corporation requiring the Other Shareholders to sell their Shares to the Third Party Purchaser on the same terms and conditions
as apply to the sale by the Selling Shareholders of their Shares to the Third Party Purchaser. Upon receipt of a Drag-Along Notice, subject
to Section 5.2, each Other Shareholder shall be obligated:

 

		(a)	if such Change of Control Transaction requires shareholder approval, to vote (in person, by proxy or by action by written consent,
as applicable) all Shares owned by or over which such Shareholder otherwise exercises voting power, in favour of such Change of Control
Transaction (including any related amendment to the Corporation’s constating documents required to implement such Change of Control
Transaction) and to vote in opposition to any and all other proposals that could reasonably be expected to delay or impair the ability
of the Corporation to consummate such Change of Control Transaction;

 

		(b)	if such Change of Control Transaction involves a Share Sale, to sell all the Shares beneficially held by such Other Shareholder to
the Person to whom the Selling Shareholders propose to sell their Shares, and, except as permitted in Section 5.2 below, on the same terms
and conditions as apply to the Selling Shareholders;

 

		(c)	to execute and deliver all related documentation and take such other action in support of the Change of Control Transaction as shall
reasonably be requested by the Corporation or the Selling Shareholders in order to carry out the terms and conditions of the Change of
Control Transaction, including, without limitation, executing and delivering instruments of conveyance and transfer, and any purchase
agreement, merger agreement, arrangement agreement, any associated indemnity agreement, or escrow agreement, any associated voting, support,
or joinder agreement, consent, waiver, governmental filing, share certificates duly endorsed for transfer (free and clear of impermissible
liens, claims and encumbrances), and any similar or related documents;

 

		(d)	not to deposit, and to cause their Eligible Transferee not to deposit, except as provided in this Agreement, any Shares of the Corporation
owned by such party or Eligible Transferee in a voting trust or subject any Shares to any arrangement or agreement with respect to the
voting of such Shares, unless specifically requested to do so by the acquirer in connection with the Change of Control Transaction;

 

		(e)	to refrain from (i) exercising any dissent rights under applicable law at any time with respect to such Change of Control Transaction,
or (ii); asserting any claim or commencing any suit (x) challenging the Change of Control Transaction
or this Agreement, or (y) alleging a breach of any fiduciary duty of the Selling Shareholders or any member of the Board in connection
with the evaluation, negotiation or entry into the Change of Control Transaction, or the consummation of the transactions contemplated
thereby; and

 

    -13-

     

    

 

		(f)	if the Selling Shareholders, in connection with such Change of Control Transaction, appoint a shareholder representative (the
                                                             “Shareholder Representative”) with respect to matters affecting the Shareholders under the applicable definitive
                                                             transaction agreements in connection with such Change of Control Transaction, (x) to consent to (i) the appointment of such
                                                             Shareholder Representative, (ii) the establishment of any applicable escrow, expense or similar fund in connection with any
                                                             indemnification or similar obligations, and (i) the payment of such Shareholder’s
pro rata portion (from the applicable escrow or expense fund or otherwise) of any and all reasonable fees and expenses to such Shareholder
Representative in connection with such Shareholder Representative’s services and duties in connection with such Change of Control
Transaction and its related service as the representative of the Shareholders, and (y) not to assert any claim or commence any suit against
the Shareholder Representative or any other Shareholder with respect to any action or inaction taken or failed to be taken by the Shareholder
Representative, within the scope of the Shareholder Representative’s authority, in connection with its service as the Shareholder
Representative, absent fraud, gross negligence or willful misconduct.

 

		5.2	Conditions

 

Notwithstanding anything to the contrary set
forth herein, a Shareholder will not be required to comply with Section 5.1 in connection with any proposed Change of Control Transaction
(the “Proposed Sale”), unless:

 

		(a)	any representations and warranties to be made by such Shareholder in connection with the Proposed Sale are limited to representations
and warranties related to authority, ownership and the ability to convey title to such Shares, including, but not limited to, representations
and warranties that (i) the Shareholder holds all right, title and interest in and to the Shares such Shareholder purports to hold, free
and clear of all liens and encumbrances, (ii) the obligations of the Shareholder in connection with the transaction
have been duly authorized, if applicable, (iii) the documents to be entered into by the Shareholder have been duly executed by the Shareholder
and delivered to the acquirer and are enforceable (subject to customary limitations) against the Shareholder in accordance with their
respective terms; and (iv) neither the execution and delivery of documents to be entered into by the Shareholder in connection with the
transaction, nor the performance of the Shareholder’s obligations thereunder, will cause a breach or violation of the terms of the
Shareholder’s constating documents (if applicable), any agreement to which the Shareholder is a party, or any law or judgment, order
or decree of any court or governmental agency that applies to the Shareholder;

 

		(b)	the Shareholder is not liable for the breach of any representation, warranty or covenant made by any other person (except for an Affiliate
or Eligible Transferee of such Shareholder) in connection with the Proposed Sale, other than
the Corporation (except to the extent that funds may be paid out of an escrow established to cover breach of representations, warranties
and covenants of the Corporation as well as breach by any Shareholder of any of identical representations, warranties and covenants provided
by all Shareholders);

 

    -14-

     

    

 

		(c)	liability shall be limited to such Shareholder’s applicable share (determined based on the respective proceeds payable to each
Shareholder in connection with such Proposed Sale) of a negotiated aggregate indemnification amount that applies equally to all Shareholders
but that in no event exceeds the amount of consideration otherwise payable to such Shareholder in connection with such Proposed Sale,
except with respect to claims related to fraud by such Shareholder, the liability for which need not be limited as to such Shareholder;
and

 

		(d)	upon the consummation of the Proposed Sale, each Shareholder will receive the same form of consideration for their Shares and same
amount of consideration per Share as is received by other Shareholders in respect of their Shares, and if any Shareholder is given a choice
as to the form of consideration to be received as a result of the Proposed Sale, all Shareholders will be given the same option.

 

ARTICLE 6

TAG-ALONG RIGHTS

 

		6.1	Tag-Along Offer

 

In the event that the Selling Shareholders receive
and wish to accept a Third Party Offer, and such Selling Shareholders do not deliver a Drag-Along Notice in accordance with Section 5.1,
then such Selling Shareholders shall, within five Business Days from the receipt of a Third Party Offer, deliver written notice of the
proposed sale to the Corporation and the Other Shareholders, which notice shall contain (i) all material information regarding the consideration
and terms and conditions of the proposed sale, including the identity of the Third Party Purchaser(s) and the number of Shares it proposes
to purchase from the Selling Shareholders, and (ii) an offer in writing to each of the Other Shareholders to purchase all the Shares held
by the Other Shareholders (the “Tag-Along Offer”), on terms and conditions identical to those contained in the Third
Party Offer, except that the obligations of the Third Party Purchaser under the Tag-Along Offer may be conditional upon completion of
the purchase of the Shares held by the Selling Shareholders.

 

		6.2	Tag-Along Acceptance

 

Each of the Other Shareholders may exercise
its right to accept the Tag-Along Offer and sell all but not less than all of its Shares to the Third Party Purchaser on the same
terms and conditions as set out in the Tag-Along Offer, by giving written notice to this effect (a “Tag-Along
Acceptance”) to the Selling Shareholders and the Third Party Purchaser, within ten Business Days after receipt of the
notice containing the Tag-Along Offer, failing which such Other Shareholder shall be deemed to have declined the Tag-Along Offer. A
Tag-Along Acceptance so given by an Other Shareholder shall constitute an irrevocable binding acceptance of the Tag-Along Offer, and
a binding contract of purchase and sale between the Other Shareholder and the Third Party Purchaser for the purchase and sale of all
the Shares owned by the Other Shareholder, subject only to completion of the sale of the Shares held by the Selling Shareholders to
the Third Party Purchaser. The Selling Shareholders may not complete the sale of the Shares to the Third Party Purchaser unless the
Third Party Purchaser contemporaneously purchases the Shares from the Other Shareholders that have submitted a Tag-Along Acceptance
on the terms and conditions of the Tag-Along Offer.

 

    -15-

     

    

 

ARTICLE 7

CLOSING PROCEDURES

 

		7.1	Time and Place of Closing

 

The following provisions
shall apply to any Transfer of Securities between Shareholders or between Shareholders and the Corporation pursuant to the terms of this
Agreement:

 

		(a)	The Transfer shall be completed at the Corporation’s registered office on the date specified for closing or electronically if
agreed to between the parties. At such time, the transferor(s) shall transfer to the transferee(s) good title to the Securities being
transferred free and clear of all Encumbrances and shall cause the transferred Securities to be registered in the name of the transferee
if the Securities are uncertificated or deliver or cause to be delivered to the transferee(s) certificates and other documents of title
evidencing ownership of the Securities being Transferred, duly endorsed in blank for transfer by the holders of record if such Securities
are certificated. In addition, the transferor(s) shall deliver to the Corporation all records, accounts and other documents in its possession
belonging to the Corporation. The transferee(s) shall pay the purchase price for the Securities being Transferred by certified cheque
or wire transfer.

 

		(b)	If, at the time of closing, a transferor fails to complete the subject transaction of purchase and sale for any reason, the transferee
shall have the right, if not in default under this Agreement, without prejudice to any other rights which it may have, upon payment of
that part of the purchase price payable to the transferor at the time of closing to the credit of the transferor in the main branch of
the Corporation’s bank, to execute and deliver, on behalf of and in the name of the transferor, such deeds, transfers, share certificates,
resignations or other documents as may, in the reasonable opinion of the transferee, be necessary or desirable to complete the subject
transaction. In connection with the foregoing, the transferor irrevocably nominates, constitutes and appoints the transferee as its attorney
and agent, with full power of substitution, in the name of such transferor to execute and deliver all such documents. Such appointment,
being coupled with an interest, is irrevocable by the transferor and shall not be revoked by the insolvency, bankruptcy, death, disability
or incapacity of the transferor or its Principal. The transferor hereby ratifies and confirms and agrees to ratify and confirm all that
the transferee may lawfully do or cause to be done by virtue of such appointment and power. If payment of the purchase price is deposited
in accordance with the foregoing, then from and after the date of deposit, notwithstanding that certificates or instruments evidencing
the Securities being Transferred may not have been delivered to the transferee, (i) the Transfer shall be deemed to have been fully completed
and the records of the Corporation may be amended accordingly, (ii) all right, title, benefit and interest, both at law and in equity,
in and to such Securities shall be conclusively deemed to have been Transferred and become vested in the transferee
and (iii) all right, title, benefit and interest of the transferor or of any other person (other than the transferee) having an interest
in such Securities, legal or equitable, in any capacity whatsoever shall cease.

 

    -16-

     

    

 

		7.2	Governmental Approvals

 

If any governmental approval is required by a transferee
of Securities under any provision of this Agreement, then, notwithstanding anything contained in this Agreement, the time period specified
in this Agreement for acceptance of the offer by such transferee shall be extended for an additional 90 days to permit such transferee
to obtain the necessary governmental approval. Any such application for governmental approval shall be the sole responsibility of such
transferee who shall also be responsible for all costs and expenses incurred in connection therewith.

 

ARTICLE 8

CONFIDENTIALITY AND ADDITIONAL
COVENANTS

 

		8.1	Confidentiality

 

(a) No
party shall, at any time or under any circumstances, without the consent of the Corporation, directly or indirectly communicate or disclose
to any person (other than the other parties and its or their employees, directors, agents, advisors and representatives) or make use of
any confidential knowledge or information howsoever acquired by such party relating to or concerning the customers, products, technology,
intellectual property, trade secrets, systems or operations, or other confidential information regarding the property, business and affairs
of the Corporation (collectively, “Information”), except for (i) Information that becomes generally known to the public
other than through a breach of this Agreement, (ii) Information that is lawfully obtained from a third party without breach of this Agreement
by the party, and (iii) Information that is required to be disclosed by law or by the applicable regulations or policies of any regulatory
agency of competent jurisdiction or any stock exchange, provided that the party gives the Corporation prompt written notice of the compelled
disclosure and cooperates with the Corporation, at the Corporation’s expense, in seeking a protective order or any other protections
available to limit the disclosure of the Information.

 

(b) Nothing
in this Section 8.1 shall preclude a Shareholder from using or disclosing Information in the course of such Shareholder performing his
or her duties as an employee, consultant or Director of the Corporation or a subsidiary of the Corporation.

 

(c) If
a Shareholder ceases to be a shareholder of the Corporation, the Shareholder shall use all reasonable efforts to ensure that all Information
and all copies thereof are either destroyed or returned to the Corporation if the Corporation so requests, and shall not, directly or
indirectly, use for the Shareholder’s own purposes, any Information discovered or acquired by the Shareholder or the Shareholder’s
advisors. Each party’s obligations under this Article 8 shall be in addition to and not in derogation of any other obligation of
confidentiality owed to the Corporation by such party.

 

(d) Each
party hereby agrees that all the restrictions in this Article 8 are reasonable and valid and all defences to the strict enforcement thereof
by the Corporation and/or the other parties are hereby waived.

 

    -17-

     

    

 

		8.2	Equitable Remedies

 

Each of the parties acknowledges that disclosure
of any Information in contravention of Section 8.1 may cause significant harm to the Corporation and that remedies at law may be inadequate
to protect against a breach of Section 8.1. Accordingly, each of the parties acknowledges that the Corporation is entitled, in addition
to any other relief available to it, to the granting of injunctive relief, specific performance and any other equitable remedies, without
proof of actual damages or the requirement to establish the inadequacy of any of the other remedies available to it. Each of the parties
covenants not to assert any defense in proceedings regarding the granting of an injunction or specific performance based on the availability
to the Corporation of any other remedy.

 

		8.3	Non-Solicitation

 

During the applicable Restriction Period, each Shareholder
and its Principal shall not, directly or indirectly through any other person or entity, (a) induce or attempt to induce (i) any person
who is an employee of the Corporation or any subsidiary of the Corporation to leave such employment, or in any way interfere with the
relationship between the Corporation or any subsidiary of the Corporation and any of their respective employees or (ii) any person who
is an independent contractor of the Corporation or any subsidiary of the Corporation to terminate its contract with the Corporation or
any subsidiary of the Corporation, or in any way interfere with the relationship between the Corporation or any subsidiary of the Corporation
and any of their respective independent contractors, provided that general media advertising for employment or related opportunities that
is not targeted towards the Corporation’s employees or independent contractors shall not be deemed to be a breach of the foregoing
clause (i) or (ii), (b) hire any person who is or was an employee or an independent contractor of the Corporation or a subsidiary of the
Corporation during the applicable Restriction Period within 12 months following the termination of the employment or the contract of such
person with the Corporation or a subsidiary of the Corporation, (c) contact or solicit any client or customer of the Corporation or a
subsidiary of the Corporation for the purpose of selling, offering or supplying to such client or customer any products or services which
are the same as the products and services sold, offered or supplied by the Corporation or any subsidiary of the Corporation, or (d) induce
or attempt to induce any customer, supplier, licensee, licensor, franchisee or other person or entity having business relations with the
Corporation or a subsidiary of the Corporation to cease doing business with the Corporation or a subsidiary of the Corporation, or in
any way interfere with the relationship between the Corporation or a subsidiary of the Corporation and any such customer, supplier, licensee,
licensor, franchisee or person or entity having business relations with the Corporation or any subsidiary of the Corporation (including
making any negative or disparaging statements or communications regarding the Corporation or any subsidiary of the Corporation).

 

		8.4	Non-Disparagement

 

No Shareholder shall engage in any pattern of
conduct that involves the making or publishing of written or oral statements or remarks (including the repetition or distribution of derogatory
rumours, allegations, negative reports or comments) which are disparaging, deleterious or damaging in any material respect to the integrity,
reputation or goodwill of the Corporation, any of its subsidiaries or their respective ownership or management.

 

    -18-

     

    

 

		8.5	Non-Merger

 

(a) Each
Management Shareholder or Principal who entered into an employment agreement or consulting agreement with the Corporation or any subsidiary
of the Corporation acknowledges and agrees that he or she is bound by the provisions of his or her employment agreement or consulting
agreement, as applicable, and that such agreement and Section 8.3 and 8.4 are separate covenants, which shall not merge into this Agreement.

 

(b) It
is acknowledged and agreed that the Corporation shall hold the benefit of each of the covenants made in Section 8.3 and 8.4 and this Section
8.5 in favour of any subsidiary of the Corporation (if any) in trust for the benefit of such subsidiary and that the Corporation shall
be entitled to enforce the rights of such subsidiary hereunder on its behalf, if applicable.

 

ARTICLE 9

AMENDMENT AND TERMINATION

 

		9.1	Amendments

 

This Agreement may only be amended by an instrument
in writing duly executed by the Corporation and the Shareholder Super-Majority, and any such amendment shall be binding on each of the
parties to this Agreement as if each such party executed and delivered such amendment. Notwithstanding the foregoing, no amendment that
would have the effect of a Shareholder being treated in a materially adverse manner will be permitted without the written consent of such
Shareholder, provided that if such Shareholder is not treated differently in any material respect from other holders of the same class
or series of Shares, then such amendment will be valid with the prior approval of the Shareholder Super-Majority.

 

		9.2	Term and Termination Events

 

This Agreement shall take effect upon its execution
by all parties hereto and shall remain in effect until terminated in accordance with the terms hereof. This Agreement shall be automatically
terminated (without prior notice) upon an IPO or the date upon which:

 

		(a)	the Shareholder Super-Majority agree in writing to terminate this Agreement;

 

		(b)	the Corporation is dissolved, liquidated or formally wound-up; or

 

		(c)	no Securities remain outstanding or all of the Securities are held by only one person.

 

		9.3	Surviving Obligations

 

The termination of this Agreement shall not
affect (a) the right of any party to whom money is owed or by whom damages can be claimed hereunder at the time of termination to
receive that money or compensation in accordance with the provisions hereof or (b) any other rights or obligations which arose
hereunder in respect of matters occurring prior to or concurrent with such termination. Without limiting the generality of the
foregoing, the provisions of this Article 9 shall survive the termination of this Agreement.

 

    -19-

     

    

 

ARTICLE 10

MISCELLANEOUS

 

		10.1	Notices

 

(a) Any
notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered in person, by email
or sent by registered mail, charges prepaid, addressed as follows: (i) if to the Corporation: Triage Technologies Inc., 1 Adelaide Street
East, Suite 3001, Toronto, ON M5C 2V9, Attention: Tory Jarmain, email: tory@triage.com, and (ii) if to the Shareholders, as set out on
the register of shareholders of the Corporation.

 

(b) Any
such notice or other communication, if delivered: (i) by email, shall be deemed to have been given on the day on which it was transmitted
if transmitted on a Business Day prior to 5:00 p.m. at the place of receipt or, otherwise, on the next following Business Day;

(ii) by personal delivery, shall be deemed to have been given when
delivered in fact; or (iii) by registered mail, shall be deemed to have been given on the fourth Business Day following the date of mailing;
provided, however, that if at the time of mailing or within three Business Days thereafter there is or occurs a labour dispute or other
event which might reasonably be expected to disrupt the delivery of documents by mail, any notice or other communication hereunder shall
be delivered by email.

 

(c) Any
party may at any time change its address for service from time to time by giving notice in accordance with this Section 10.1.

 

		10.2	Management Shareholder Power of Attorney

 

Each Management Shareholder hereby constitutes
and appoints, effective as of the date of termination of such Management Shareholder as an employee of, or consultant to, the Corporation
or any of its subsidiaries, any officer or Director of the Corporation as a true and lawful attorney for, in the name and on behalf of
such Management Shareholder to execute and deliver any and all resolutions, proxies, voting trust or other agreements, or other instruments
required in order to ensure such Management Shareholder’s compliance with its obligations under this Agreement, in each case in
respect of any and all Securities held by such Management Shareholder from time to time. This power of attorney is hereby coupled with
an interest and shall be irrevocable by each of the terminated Management Shareholders. This power of attorney is not intended to be a
continuing power of attorney or similar power of attorney within the meaning of and governed by applicable substitute decision, living
will or estate planning legislation in any of the provinces or territories of Canada (a “CPOA”). The execution of this
power of attorney does not terminate any CPOA granted previously and this power of attorney is not terminated by the execution by any
Management Shareholder in the future of a CPOA and each such Management Shareholder hereby agrees not to take any action that results
in the termination of this power of attorney. Any proxy executed and delivered pursuant hereto relating to any meeting of Shareholders
or any adjournments thereof shall revoke any proxy otherwise executed and delivered by or on behalf of a terminated Management Shareholder
with respect to such meeting or any adjournments thereof, regardless of the respective dates thereof. Each terminated Management Shareholder
hereby ratifies and confirms and agrees to ratify and confirm all that such attorney may lawfully do or cause to be done by virtue of
the provisions of this Section 10.2.

 

    -20-

     

    

 

		10.3	Amendment and Restatement

 

This Agreement amends and restates the Original
Shareholders’ Agreement in its entirety. Each of the parties agrees and confirms that all of the rights, liabilities and obligations
under the Original Shareholders’ Agreement arising on or prior to the date of this Agreement continue in full force and effect,
as further amended and restated in accordance with the terms of this Agreement.

 

		10.4	Enurement

 

Except as otherwise provided herein, this Agreement
will enure to the benefit of and will be binding upon the parties and their respective successors and assigns.

 

		10.5	Entire Agreement

 

This Agreement, together with the agreements
and other documents to be delivered pursuant to this Agreement, constitutes the entire agreement between the parties pertaining to the
subject matter of this Agreement and supersedes all prior agreements, term sheets, understandings, negotiations and discussions between
the parties, whether written or oral. There are no representations, warranties or other agreements between the parties in connection with
the subject matter of this Agreement except as specifically set out in this Agreement.

 

		10.6	Independent Legal Advice

 

Each Shareholder and Principal acknowledges that
he, she or it: (a) has had sufficient time to review and consider this Agreement thoroughly; (b) has read and understands the terms of
this Agreement and his, her or its rights and obligations hereunder; (c) has been advised by the Corporation to seek independent legal
advice; (d) has sought such independent legal advice or deliberately decided not to do so; and (e) is executing this Agreement voluntarily.

 

		10.7	Assignment

 

Except as otherwise provided herein, no party may
assign any of its rights or obligations under this Agreement, except, for certainty, to an Eligible Transferee, without the prior written
consent of the Board.

 

		10.8	No Third-party Beneficiaries

 

Other than as provided in Section 8.5(b), this Agreement
is for the sole benefit of the parties (and their respective heirs, executors, administrators, other personal representatives, successors
and permitted assigns) and nothing herein, express or implied, is intended to or shall confer upon any other person, including any creditor
of the Corporation, any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.

 

		10.9	Counterparts

 

This Agreement may be executed in any
number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall
constitute one and the same agreement. A copy of this Agreement executed by any party and transmitted by email shall be binding upon
the parties in the same manner as an original executed copy that was delivered in person.

 

[The remainder of this page
is intentionally left blank.]

 

    -21-

     

    

 

IN WITNESS WHEREOF this Agreement has been executed by the
parties pursuant to Section 3.4 of the Original Shareholders’ Agreement.

 

	 	CORPORATION
	 	 	 	 
	 	TRIAGE TECHNOLOGIES INC.
	 	 	 	 
	 	by 	 
	 	 	Name: 	Tory Jarmain
	 	 	Title:	Chief Executive Officer
	 	 	 	 
	 	SHAREHOLDERS
	 	 	 	 
	 	by	 
	 		Tory Jarmain

 

Signature Page – Triage Shareholders’ Agreement

 

     

     

    

 

	 	ADVANCED HUMAN IMAGING LIMITED
	 	 	 	 
	 	by	 
	 	 	Name: 	Vlado Bosanac
	 	 	Title:	Chief Executive Officer
	 	 	 	 
	 	 	 
	 	 	Name:	Steven Richards
	 	 	Title:	Chief Financial Officer

 

Signature Page – Triage Shareholders’ Agreement

 

     

     

    

 

	 	by	 
	 	 	Eric Lau

 

Signature Page – Triage Shareholders’ Agreement

 

     

     

    

 

SCHEDULE A FORM OF COUNTERPART

 

 TO: TRIAGE TECHNOLOGIES INC.

 

 AND TO: THE OTHER PARTIES TO THE SHAREHOLDERS’ AGREEMENT REFERRED TO BELOW

 

The undersigned hereby acknowledges and confirms
that the undersigned has (i) received a copy of the amended and restated unanimous shareholders’ agreement dated March 31, 2021
between Triage Technologies Inc. (the “Corporation”) and its shareholders, as amended to the date hereof (the “Shareholders’
Agreement”), a copy of which is attached hereto, and (ii) read and understood fully the provisions of the Shareholders’
Agreement.

 

The undersigned hereby covenants and agrees to be
bound by the Shareholders’ Agreement, as the same may be amended from time to time in accordance with the provisions thereof, as
a Shareholder in the same manner and to the same extent as if the undersigned had been an original party to the Shareholders’ Agreement.

 

The undersigned acknowledges and confirms that
prior to executing this Counterpart, the Corporation requested that the undersigned obtain legal advice with respect to the undersigned’s
rights and obligations under the Shareholders’ Agreement, and, furthermore, the undersigned confirms and agrees that:

 

		(a)	the undersigned has executed this Counterpart on the undersigned’s own volition and without any duress whatsoever from the Corporation,
the Shareholders or any other person; and

 

		(b)	if the undersigned did not obtain legal advice prior to executing this Counterpart, the undersigned will not in any proceeding relating
to the enforcement of rights or obligations under the Shareholders’ Agreement raise that fact as a defence or otherwise.

 

Unless otherwise defined in this Counterpart, all
terms used above that are defined in the Shareholders’ Agreement have the respective meanings given to them in the Shareholders’
Agreement.

 

	 	Signature:	 
	 	 	 
	 	Name:	 
	 	 	(please print)
	 	 	 
	 	Address:	 
	 	 	 
	 	Email:	 
	 	 	 
	 	Number and Class of Shares:	 
	 	 	 
	 	Name of Principal:Exhibit 10.16

 

Execution Version

 

TRIAGE TECHNOLOGIES INC.

(a
company incorporated under the federal laws of Canada)

(Company)

 

and

 

ADVANCED HUMAN IMAGING LIMITED ACN 602 111 115

(Investor)

 

 

 

SUBSCRIPTION AGREEMENT

 

 

 

     

     

    

 

TABLE OF CONTENTS

  

	1.	DEFINITIONS AND INTERPRETATION	3
	 	 	 	 
	 	1.1	Definitions	3
	 	1.2	Interpretation	8
	 	1.3	Business Day	9
	 	1.4	References to the calculation of time	9
	 	1.5	Fractional entitlements	10
	 	1.6	Time is of the Essence	10
	 	 	 	 
	2.	SUBSCRIPTION FOR SUBSCRIPTION SHARES	10
	 	 	 	 
	 	2.1	Application	10
	 	2.2	Subscription	10
	 	2.3	Issue	12
	 	2.4	Conditions of Issuance of Company Shares	12
	 	 	 	 
	3.	REQUEST FOR FURTHER INVESTMENT	12
	 	 	 	 
	4.	SHAREHOLDER APPROVAL	13
	 	 	 	 
	5.	WARRANTIES	13
	 	 	 	 
	 	5.1	Mutual Warranties	13
	 	5.2	Investor Warranties	14
	 	5.3	Company Warranty	15
	 	 	 	 
	6.	RIGHT OF FIRST OFFER	15
	 	 	 	 
	 	6.1	Right of First Offer	15
	 	6.2	Permitted Offering	16
	 	6.3	Termination of Right of First Offer	16
	 	 	 	 
	7.	 UNDERTAKINGS BY THE COMPANY	17
	 	 	 	 
	 	7.1	Company Undertakings	17
	 	7.2	Investor Undertakings	17
	 	 	 	 
	8.	DEFAULT	17
	 	 	 	 
	 	8.1	Event of Default	17
	 	8.2	Non-Defaulting Party’s Powers on an Event of Default	18
	 	 	 	 
	9.	CONFIDENTIALITY	18
	 	 	 	 
	 	9.1	Confidential Information	18
	 	9.2	Reasonable endeavours	19
	 	9.3	Survival on termination	20
	 	 	 	 
	10.	NOTICES	20
	 	 	 	 
	 	10.1	Form of notice	20
	 	10.2	Means of giving notices	20
	 	10.3	Specified address for service	20
	 	10.4	Change of Address	20
	 	10.5	Receipt of notices	21
	 	 	 	 
	11.	NOVATION	21
	 	 	 	 
	 	11.1	AHI USA	21
	 	11.2	References	21
	 	11.3	Release by the Company	21
	 	11.4	Release by the Investor	22

 

    i

     

    

 

	12.	MISCELLANEOUS	22
	 	 	 	 
	 	12.1	Termination	22
	 	12.2	Effect of Termination	22
	 	12.3	Amendments and Waivers	22
	 	12.4	Taxes and withholdings	22
	 	12.5	Further assurance	22
	 	12.6	Governing law	23
	 	12.7	Costs	23
	 	12.8	Severance	23
	 	12.9	Entire Agreement	23
	 	12.10	Conflicts	23
	 	12.11	Counterparts	23
	 	 	 	 
	SCHEDULE A	25
	 	 	 	 
	SCHEDULE B	26

 

    ii

     

    

 

THIS AGREEMENT is made the 31st day of March, 2021

 

 

BE TWE
E N

 

 

TRIAGE TECHNOLOGIES INC. (a company incorporated
under the federal laws of Canada) of 1 Adelaide Street East, Suite 3001 Toronto, Ontario M5C 2V9 Canada (Company);

 

AND

 

ADVANCED HUMAN IMAGING LIMITED
(ACN 602 111 115) of Suite 5, 71-73 South Perth Esplanade, South Perth WA 6151 Australia (Investor).

 

 

RE CI T
A LS

 

 

	A.	The Investor hereby irrevocably subscribes for and agrees to purchase 4,466,748
Subscription Shares for aggregate consideration of $6,000,000, payable in cash and AHI USA Shares or AHI ASX Shares (each as defined below)
(the Aggregate Subscription Amount), in tranches on the terms and conditions contained in this Agreement.

 

	B.	On 3 December 2020 (Toronto time), the Investor advanced $500,000 to the Company
as a prepayment of a portion of the Aggregate Subscription Amount.

 

	C.	On 16 March 2021 (Toronto time), the Investor advanced a further $100,000 to the
Company as a prepayment of a portion of the Aggregate Subscription Amount.

 

	D.	The Company hereby agrees to issue a total of 4,466,748 Subscription Shares to
the Investor in tranches on the terms and conditions contained in this Agreement.

 

	E.	The Investor and the Company will enter into a software reseller agreement (the
Reseller Agreement) in connection with the entering into of this Agreement, pursuant to which, among other things, the Company
will grant a non-exclusive license to the Investor to integrate the Triage Platform into the MyFiziq Platform (each as defined in the
Reseller Agreement) and the Investor will grant a non- exclusive license to the Company to commercialise the Triage Platform, as an add-on
to the MyFiziq Platform, or as a combined application.

 

IT IS AGREED as follows:

 

 

	1.	DEFINITIONS AND INTERPRETATION

 

	1.1	Definitions

 

For the purposes of this Agreement, unless the context
otherwise requires, the following capitalized terms shall have the respective meanings set out below:

 

Acceptance Period has
the meaning given to it in clause 6.1(c). Aggregate Subscription Amount has the meaning set out in the recitals. Agreement
means this agreement, including its recitals. AHI ASX Share means a fully paid ordinary Share in the Investor.

 

AHI USA means a holding company incorporated
in the USA for the purpose of acquiring the Investor in connection with a listing on NASDAQ.

 

    1

     

    

 

AHI USA Shares means shares in the common stock
of AHI USA listed on NASDAQ.

 

ASX means the Australian Securities Exchange.

 

Business Day means a day
that is not a Saturday, Sunday or public holiday in Toronto, Ontario, or Perth, Western Australia.

 

Change of Control means,
with respect to the Company or the Investor (the “relevant entity”) (a) any transaction or series of related transactions
to which the relevant entity is party in which in excess of fifty percent (50%) of the total voting power is transferred; (b) any merger,
amalgamation or consolidation of the relevant entity with or into any other entity or person, or any other corporate reorganization, other
than any such merger, amalgamation, consolidation or reorganization in which the shareholders of the relevant entity outstanding immediately
prior to such transaction continue to retain at least fifty percent (50%) of the total voting power of the relevant entity or such surviving
entity outstanding immediately after such transaction; or (c) a sale, transfer or other conveyance of all
or substantially
all of the
relevant
entity’s
assets,
or the exclusive
license of all
or substantially
all of the
relevant
entity’s
material
intellectual
property.

 

Claim means any allegation,
debt, cause of action, liability, claim, proceeding, suit or demand of any nature howsoever arising and whether present or future, fixed
or unascertained, actual or contingent whether at law, in equity, under statute or otherwise and which any party may have against another
in connection with this Agreement.

 

Company Shares means any
authorized shares in the capital of the Company, including the Subscription Shares.

 

Confidential Information has the meaning given to
it in clause 9.1.

 

Corporations Act means the Corporations Act 2001
(Cth).

 

Deemed Issue Price
means:

 

		(a)	for Subscription Shares, $1.34 per Subscription Share;

 

		(b)	for the
first $500,000 of AHI ASX Shares issued to the Company, A$0.95 per AHI ASX Share, and for any subsequent AHI ASX Shares issued
to the Company, the VWAP of AHI ASX Shares for the 5 trading days prior to the relevant Subscription Date; and

 

		(c)	for AHI USA Shares:

 

		(i)	where clause 2.2(f) applies: the price at which AHI USA Shares are listed on the NASDAQ; or

 

		(ii)	in all other cases: the VWAP of AHI USA Shares for the 5 trading days prior to the relevant Subscription
Date.

 

Defaulting Party has the meaning given to it
in clause 8.1.

 

Event of Default means any of the events set out in clause 8.1.

 

Exercise Notice has the meaning given to
it in clause 6.1(c).

 

Further Investment Notice has the meaning given
to it in clause 3(a).

 

    2

     

    

 

Listing Rules means the Listing Rules of the ASX.

 

Material
Adverse Effect means
a material
adverse effect
on the Company’s
ability to perform and comply with its obligations
under the Company Shares or on a shareholder of the Company’s rights under them.

 

NASDAQ means the NASDAQ Stock
Market.

 

Non-Defaulting Party has the meaning given to it
in clause 8.1(a).

 

Notice of Election has the meaning given to it in
clause 2.2(f).

 

Novation Date means the
date on which AHI USA completes the acquisition of the Investor.

 

Offer Notice has the meaning given to it in clause
6.1(b).

 

Offered Shares has the meaning given to it in clause
6.1(a).

 

Professional Investor means
a professional investor for the purposes of section 708(11) of the Corporations Act.

 

Reseller Agreement has the meaning set out in the
recitals.

 

Shareholder Approval means
the Investor obtaining the required approvals from its shareholders at a General Meeting to issue AHI ASX Shares to the Company.

 

Shareholders’
Agreement means the shareholders’ agreement of the Company dated April 5, 2016 and attached as Schedule A hereto.

 

Sophisticated Investor means
a sophisticated investor for the purposes of section 708(8) of the Corporations Act.

 

Subscription Amounts means the:

 

		(a)	Tranche 1 Subscription Amount;

 

		(b)	Tranche 2 Subscription Amount;

 

		(c)	Tranche 3 Subscription Amount;

 

		(d)	Tranche 4 Subscription Amount;

 

		(e)	Tranche 5 Subscription Amount; and

 

		(f)	Tranche
                                            6 Subscription Amount,

 

(each
being a Subscription Amount). 

 

Subscription
Date means:

 

		(a)	for the Tranche 1 Subscription Amount: the Tranche 1 Subscription Date;

 

		(b)	for the Tranche 2 Subscription Amount: the Tranche 2 Subscription Date;

 

		(c)	for the Tranche 3 Subscription Amount: the Tranche 3 Subscription Date;

 

    3

     

    

 

		(d)	for the Tranche 4 Subscription Amount: the Tranche 4 Subscription Date;

 

		(e)	for the Tranche 5 Subscription Amount: the Tranche 5 Subscription Date; and

 

		(f)	for the Tranche 6 Subscription Amount: the Tranche 6 Subscription Date.

 

Subscription Shares means Series C Common Shares
in the capital of the Company.

 

Third Party has the meaning given to it in clause
6.1(e).

 

Tranche 1 Subscription Amount
means $500,000. Tranche 1 Subscription Date means the date hereof. Tranche 2 Subscription Amount means:

 

		(a)	$500,000, payable in immediately available funds to an account nominated by the
Company ($100,000 of which has already been advanced as acknowledged under Recital C); and

 

		(b)	subject to Section 2.2(f), if the Novation Date:

 

		(i)	occurs by the Tranche 2 Subscription Date, $1,000,000 worth of AHI USA Shares at
the Deemed Issue Price; or

 

		(ii)	does not occur by the Tranche 2 Subscription Date, the Company will, at its sole
discretion, elect to (x) receive $1,000,000 worth of AHI ASX Shares at the Deemed Issue Price, or (y) not receive any additional consideration
under this tranche.

 

Tranche 2 Subscription Date means the earlier of
May 27, 2021 and the Novation Date.

 

Tranche 3 Further Investment Notice means the Further
Investment Notice requesting the advance of the Tranche 3 Subscription Amount.

 

Tranche 3 Subscription Amount means:

 

		(a)	$500,000, payable in immediately available funds to an account nominated by the
Company; and

 

		(b)	subject to Section 2.2(f), if the Novation Date:

 

		(i)	occurs:

 

		(A)	by the Tranche 2 Subscription Date, $500,000 worth of AHI USA Shares at the Deemed
Issue Price; or

 

		(B)	by the Tranche 3 Subscription Date, but after the Tranche 2 Subscription Date, $1,500,000
worth of AHI USA Shares at the Deemed Issue Price; or

 

		(ii)	does not occur by the Tranche 3 Subscription Date, the Company will, at its sole
discretion, elect to (x) receive $1,500,000, less the dollar value at the time of issuance
of any AHI ASX Shares previously received
by the Company pursuant to any prior Subscription Amount, worth of AHI ASX Shares at the Deemed Issue Price, or (y) not receive any additional
consideration under this tranche.

 

    4

     

    

 

Tranche 3 Subscription Date
means the date that is 60 days after the Investor receives the Tranche 3 Further Investment Notice or such earlier date as the parties
may mutually agree in writing.

 

Tranche 4 Further Investment
Notice means the Further Investment Notice requesting the advance of the Tranche 4 Subscription Amount.

 

Tranche 4 Subscription
Amount means:

 

		(a)	$500,000, payable in immediately available funds to an account nominated by the Company; and

 

		(b)	subject to Section 2.2(f), if the Novation Date:

 

		(i)	occurs:

 

		(A)	by the Tranche 3 Subscription Date, $500,000 worth of AHI USA Shares at the Deemed
Issue Price; or

 

		(B)	by the Tranche 4 Subscription Date, but after the Tranche 3 Subscription Date, $2,000,000
worth of AHI USA Shares at the Deemed Issue Price; or

 

		(ii)	does not occur by the Tranche 4 Subscription Date, the Company will, at its sole
discretion, elect to (x) receive $2,000,000,
less the dollar value at the time of issuance of any AHI ASX Shares previously received by the Company pursuant to any prior Subscription
Amount, worth of AHI ASX Shares at the Deemed Issue Price, or (y) not receive any additional consideration under this tranche.

 

Tranche 4 Subscription Date
means the date that is 60 days after the Investor receives the Tranche 4 Further Investment Notice or such earlier date as the parties
may mutually agree in writing.

 

Tranche 5 Further Investment
Notice means the Further Investment Notice requesting the advance of the Tranche 5 Subscription Amount.

 

Tranche 5 Subscription
Amount means:

 

		(a)	$500,000, payable in immediately available funds to an account nominated by the Company; and

 

		(b)	subject to Section 2.2(f), if the Novation Date:

 

		(i)	occurs:

 

		(A)	by the Tranche 4 Subscription Date, the number of AHI USA Shares that equals $500,000
when calculated at the Deemed Issue Price; or

 

    5

     

    

 

	 	(B)	by the Tranche 5 Subscription Date, but after the Tranche 4 Subscription Date, $2,500,000 worth of AHI USA Shares at the Deemed Issue Price; or

 

		(ii)	does not occur by the Tranche 5 Subscription Date, the Company will, at its sole
discretion, elect to (x) receive $2,500,000, less the dollar value
at the time of issuance of any AHI ASX Shares previously received by the Company pursuant to any prior Subscription Amount, worth of AHI
ASX Shares at the Deemed Issue Price, or (y) not receive any additional consideration under this tranche.

 

Tranche 5 Subscription Date
means the date that is 60 days after the Investor receives the Tranche 5 Further Investment Notice or such earlier date as the parties
may mutually agree in writing.

 

Tranche 6 Further Investment
Notice means the Further Investment Notice requesting the advance of the Tranche 6 Subscription Amount.

 

Tranche 6 Subscription Amount means:

 

		(a)	$500,000, payable in immediately available funds to an account nominated by the Company; and

 

		(b)	subject to Section 2.2(f), if the Novation Date:

 

		(i)	occurs:

 

		(A)	by the Tranche 5 Subscription Date, $500,000 worth of AHI USA Shares at the Deemed
Issue Price; or

 

		(B)	by the Tranche 6 Subscription Date, but after the Tranche 5 Subscription Date, $3,000,000
worth of AHI USA Shares at the Deemed Issue Price; or

 

		(ii)	does not occur by the Tranche 6 Subscription Date, $3,000,000, less the dollar
value at the time of issuance of any AHI ASX Shares previously received by the Company pursuant to any prior Subscription Amount, worth
of AHI ASX Shares at the Deemed Issue Price.

 

Tranche 6 Subscription Date
means the date that is 60 days after the Investor receives the Tranche 6 Further Investment Notice or such earlier date as the parties
may mutually agree in writing.

 

Treasury Offer has the meaning given to it in clause
6.1.

 

VWAP means volume weighted average price.

 

Warrantor has the meaning given to it in clause
5.1.

 

	1.2	Interpretation

 

In this Agreement:

 

		(a)	headings are for convenience only and do not affect its interpretation;

 

    6

     

    

 

		(b)	specifying anything after the words “include” or “for example”
or similar expressions does not limit what else is included,

 

and, unless the context otherwise requires:

 

		(c)	the expression person includes
an individual, the estate of an individual, a corporation, an authority, an association or joint venture (whether incorporated or unincorporated),
a partnership and a trust;

 

		(d)	a reference to any party includes that party’s executors, administrators,
successors and permitted assigns, including any person taking by way of novation;

 

		(e)	a reference to any document (including this Agreement) is to that document as varied,
novated, ratified or replaced from time to time;

 

		(f)	a reference to any statute or to any statutory provision includes any statutory
modification or re-enactment of it or any statutory provision substituted for it, and all ordinances, by-laws, regulations, rules and
statutory instruments (however described) issued under it;

 

		(g)	words importing the singular include the plural
(and vice versa) and words indicating a gender include every other gender;

 

		(h)	reference to parties, clauses or Articles are
references to parties, clauses and Articles of this Agreement;

 

		(i)	where a word or phrase is given a defined meaning, any other part of speech or
grammatical form of that word or phrase has a corresponding meaning;

 

		(j)	other parts of speech and grammatical forms of a word or phrase defined in this
Agreement have a corresponding meaning;

 

		(k)	a reference to $ or dollars is to the currency of the United States of America;
and

 

		(l)	any amount computed or determined in whole or in part in a currency other than
the U.S. dollar shall be converted to an amount expressed in U.S. dollars by the payor using the indicative exchange rate provided by the Bank of Canada for the day on which the particular amount is paid or, if no indicative rate is provided for that day, at the most recent indicative rate preceding that day, and paid in U.S. dollars.

 

	1.3	Business Day

 

Where the day on or by which any thing is to be done is
not a Business Day, that thing must be done on or by the immediately preceding Business Day.

 

	1.4	References to the calculation of time

 

		(a)	Unless otherwise indicated, a reference to a time of day means that time of day
in Toronto, Ontario.

 

    7

     

    

 

		(b)	For the purposes of determining the length of a period (but not its commencement)
a reference to:

 

		(i)	a day means a period of time commencing at midnight and ending 24 hours later; and

 

		(ii)	a month means a calendar month.

 

		(c)	Any time period within which a payment is to be made or any other action is to
be taken hereunder shall be calculated excluding the day on which the period commences and including the day on which the period ends.

 

	1.5	Fractional entitlements

 

Fractional entitlements to any
Subscription Shares, AHI USA Shares or AHI ASX Shares that are to be issued pursuant to this Agreement will be rounded to the nearest
whole number.

 

	1.6	Time is of the Essence

 

Time shall be of the essence of this
Agreement.

 

 

	2.	SUBSCRIPTION FOR SUBSCRIPTION SHARES

 

	2.1	Application

 

The Investor agrees to subscribe
for, and the Company agrees to issue to the Investor, the 4,466,748 Subscription Shares in tranches in accordance with this Agreement,
in consideration for the Subscription Amounts.

 

	2.2	Subscription

 

		(a)	On the Tranche 1 Subscription Date, the payment referenced in Recital B shall be
fully set-off against the Tranche 1 Subscription Amount.

 

		(b)	The Investor must advance the cash component of the Tranche 2 Subscription Amount
and each subsequent Subscription Amount to the Company on the relevant Subscription Date, provided that, on the Tranche 2 Subscription
Date, the payment referenced in Recital C shall be set-off in part against the cash component of the Tranche 2 Subscription Amount.

 

		(c)	Subject to clauses 2.2(d) and (e), the Investor must issue any share component of
the Tranche 2 Subscription Amount and each subsequent Subscription Amount to the Company on the earlier of:

 

		(i)	the relevant Subscription Date; and

 

		(ii)	the date specified under clause 2.2(f) (if applicable).

 

		(d)	Where the Investor is required to issue any AHI ASX Shares under this Agreement
it must:

 

		(i)	allot and issue the relevant AHI ASX Shares to the Company;

 

    8

     

    

 

		(ii)	enter the Company in the Investor’s register of members as the holder of
the relevant AHI ASX Shares; and

 

		(iii)	following the issue of the relevant AHI ASX Shares:

 

		(A)	send holding statements in respect of the relevant AHI ASX Shares to the Company
in accordance with applicable law;

 

		(B)	apply to ASX for official quotation of the relevant AHI ASX Shares in the same
class and on the same terms as all other AHI ASX Shares quoted on ASX on the date of issue; and

 

		(C)	shall lodge with ASX a notice in accordance with section 708A(5)(e) of the Corporations
Act.

 

		(e)	If the Investor is unable to comply with the requirements of section 708A(5) of
the Corporations Act for any reason:

 

		(i)	the Investor shall use reasonable endeavours to ensure the relevant AHI ASX Shares
are able to be freely traded on ASX in compliance with the requirements of the ASX Listing Rules and the Corporations Act as soon as reasonably
practicable after the relevant issue date; and

 

		(ii)	the Company agrees that the Investor may place a holding lock on such AHI ASX Shares
until those requirements have been met.

 

		(f)	Where the Novation Date occurs prior to a Subscription Date, the Company may, within
21 days after the Novation Date, elect by providing notice in writing to the Investor (the Notice of Election) to immediately receive
the share component of all of the Subscription Amounts, in which case:

 

		(i)	the Investor must issue to the Company $3,000,000, less the dollar value at the
time of issuance of any AHI ASX Shares previously received by the Company pursuant to any prior Subscription Amount, worth of AHI USA
Shares at the Deemed Issue Price in respect thereof on the date which is 60 days after the Investor receives the Company’s Notice
of Election; and

 

		(ii)	subject
to clause
2.4 and the
Company’s
receipt
of the AHI USA
Shares referred to in clause 2.2(f)(i), the Company must issue to the Investor $3,000,000, less the dollar value at the time of issuance
of any AHI ASX Shares previously received by the Company pursuant to any prior Subscription Amount, worth of Subscription Shares at the
Deemed Issue Price on the date which is 5 Business Days after the Investor receives the Company’s Notice of Election.

 

Notwithstanding any election by
the Company pursuant to clause 2.2(f), the cash component of each Subscription Amount will continue to be paid at the times provided
for under clause 2.2(b) in all cases. The Investor shall provide the Company with reasonable advance notice of the occurrence of the
Novation Date.

 

    9

     

    

 

	2.3	Issue

 

Subject to clause 2.2(f), 2.4
and the receipt by the Company of the applicable Subscription Amount in accordance with clause 2.2, the Company must do each of the following
on each applicable Subscription Date:

 

		(a)	issue to the Investor the amount of Subscription Shares that, when multiplied by
the Deemed Issue Price, equals the applicable Subscription Amount;

 

		(b)	deliver a share certificate or notice of uncertificated shares for the relevant
Subscription Shares to the Investor; and

 

		(c)	ensure the Investor is registered as the holder of the relevant Subscription Shares
in the Company’s
share register.

 

The representations and warranties
of the Investor set out in Section 5.2 shall be deemed to be made again on each date the Investor is issued Subscription Shares under
this Agreement.

 

	2.4	Conditions of Issuance of Company Shares

 

		(a)	The Company and the Investor shall use commercially reasonable efforts to enter
into an amended and restated shareholders’ agreement with the other shareholders of the Company on the Tranche 1 Subscription Date,
pursuant to which the Shareholders’ Agreement will be amended and restated in its entirety. Notwithstanding anything to the contrary
in this Agreement, any issuance of Company Shares (including Subscription Shares) by the Company to the Investor under this Agreement
shall be conditional upon (i) the Investor executing and being bound by such amended
and restated
shareholders’
agreement
(or such
other shareholders’
agreement
of the Company
in effect at the time
of issuance) and (ii) the satisfaction of all requirements under applicable securities laws
in respect of the private placement of such Company Shares.

 

		(b)	The Investor acknowledges that (i) the Company is not a reporting issuer or the
equivalent in any jurisdiction, (ii) the Company Shares are not listed on any stock exchange, (iii) no public market exists for the Company
Shares, and (iv) the Company Shares are subject to restrictions on transferability and resale and may not be transferred or resold except
as permitted
under applicable
securities
laws, the
Company’s
constating
documents and the shareholders’ agreement of the Company in effect at the relevant time.

 

 

	3.	REQUEST FOR FURTHER INVESTMENT

 

		(a)	Any time after:

 

		(i)	in respect of the Tranche 3 Subscription Amount, the Tranche 2 Subscription Date;

 

    10

     

    

 

		(ii)	in respect of the Tranche 4 Subscription Amount, the Tranche 3 Subscription Date;

 

		(iii)	in respect of the Tranche 5 Subscription Amount, the Tranche 4 Subscription Date; and

 

		(iv)	in respect of the Tranche 6 Subscription Amount, the Tranche 5 Subscription Date;

 

the Company may demand in writing
that the Investor advance the next Subscription Amount (a Further Investment Notice) and the Investor shall advance such Subscription
Amount to the Company on the relevant Subscription Date.

 

		(b)	For the avoidance of doubt:

 

		(i)	a Further Investment Notice can only request the advance of one Subscription Amount at a time; and

 

		(ii)	each Subscription Amount can only be advanced once.

 

 

	4.	SHAREHOLDER APPROVAL

 

		(a)	The issue of AHI ASX Shares that is contemplated in this Agreement is subject to
and conditional on Shareholder Approval.

 

		(b)	If the Novation Date has not occurred by 27 May 2021, the Investor must seek Shareholder
Approval for the issue of the AHI ASX Shares component of the Tranche 2 Subscription Amount at a General Meeting to be held prior to the
Tranche 2 Subscription Date.

 

		(c)	Upon the receipt of a Further Investment Notice,
if the Novation Date has not occurred prior to receipt of such notice, the Investor must use reasonable endeavours to convene a
General Meeting prior to the relevant Subscription Date to obtain the required Shareholder Approval for the issue of the amount of AHI
ASX Shares contemplated in the Further Investment Notice.

 

		(d)	If a Shareholder Approval is required and not obtained by the applicable Subscription
Date in accordance with Section 4(c), the Investor must instead pay on such Subscription Date an amount equal to the value of the relevant
AHI ASX Shares contemplated in the Further Investment Notice in immediately available funds to an account nominated by the Company.

 

 

	5.	WARRANTIES

 

	5.1	Mutual Warranties

 

Each of the Company and the Investor
(each, a Warrantor) represents and warrants to the other, as an inducement to the other to enter into this Agreement that, at the
date of this Agreement:

 

		(a)	the execution and delivery of this Agreement has been properly authorised by all
necessary corporate action of the Warrantor;

 

    11

     

    

 

		(b)	the Warrantor is duly incorporated, validly existing and in good standing under
the laws of the jurisdiction in which it is incorporated and has full power and lawful authority to execute and deliver this Agreement
and to consummate and perform or cause to be performed its obligations under this Agreement;

 

		(c)	the execution and delivery by the Warrantor of this Agreement, the performance
by it of its obligations hereunder and compliance with the terms, conditions and provisions hereof will not conflict with or result in
a breach of any of the terms, conditions or provisions of (i) its articles or other constating documents; (ii) any law, rule or regulation
having the force of law; (iii) any indenture, mortgage, lease, agreement or instrument binding
or affecting it or its properties, including any shareholders’ agreement or partnership agreement; or (iv) any judgment, injunction,
determination or award which is binding upon it or its properties; and

 

		(d)	this Agreement constitutes a legal, valid and binding obligation of the Warrantor
enforceable against it in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium
or other laws of general application relating to or affecting the enforcement of creditors’
rights and as limited by rules or laws concerning equitable remedies.

 

	5.2	Investor Warranties

 

In addition to the warranties
given under clause 5.1, the Investor represents and warrants to the Company as an inducement to the Company to enter into this Agreement
that, at the date of this Agreement:

 

		(a)	the decision of the Investor to enter into this Agreement and subscribe for the
Subscription Shares was made in Perth, Western Australia;

 

		(b)	it is a Sophisticated Investor or Professional Investor, or is otherwise a person
who is able to be offered the Subscription Shares without disclosure under Chapter 6D of the Corporations Act, and will, on the request
of the Company, promptly provide written evidence sufficient to satisfy the Company of the same;

 

		(c)	it is an “accredited investor” as defined in Section 1.1 of National
Instrument 45-106 – Prospectus and Registration Exemption or under Section 73.3 of the Securities Act (Ontario), provided
that the Investor has (i) reviewed the substance of each category of such definition, (ii) consulted its financial, accounting or tax advisors regarding the Investor’s compliance with such definition, and (iii) communicated in writing prior to the date hereof any exchange, valuation or other risks that might reasonably be expected to result in the Investor’s failure to satisfy such definition, and provided further that the Investor shall, upon reasonable request of the Company, provide such additional financial or other information reasonably required to support such representations and warranties;

 

		(d)	it is a person to whom it is lawful to offer or issue the Subscription Shares without
a disclosure document (and is not a “U.S. Person” as defined under the U.S. Securities Act of 1933, or resident in the United
States of America or in any other place in which it would not be lawful to offer or issue the Subscription Shares);

 

    12

     

    

 

		(e)	the issuance of the Subscription Shares to the Investor does not require registration,
qualification, disclosure or any other action by the Company in the jurisdiction in which the Investor is located or in which the offer
of the Subscription Shares is received, and the Investor has satisfied itself as to the full observance of the laws of its jurisdiction
in connection with the offer of and subscription for Subscription Shares;

 

		(f)	it is aware of and accepts the risks relating to its subscription for the Subscription
Shares under this Agreement; and

 

		(g)	in deciding to subscribe for the Subscription Shares, it has:

 

		(i)	made and relied on its own enquiries and assessment of the Company, its business,
operations and prospects;

 

		(ii)	made and relied on its own assessment of, and risks relating to, the
Subscription Shares and an investment in the Company; and

 

		(iii)	not relied on any representations or
warranties made or given by or on behalf of the Company (or any of its directors, officers, employees, agents or advisers), other than
as set out in this Agreement.

 

	5.3	Company Warranty

 

In
addition to the warranties given under clause 5.1, the Company represents and warrants to the Investor as an inducement to the
Investor to enter into this Agreement that, at the date of this Agreement, the copy of the Company’s articles of incorporation that
has been provided to the Investor is a true and correct copy of the Company’s current articles of incorporation.

 

 

	6.	RIGHT OF FIRST OFFER

 

	6.1	Right of First Offer

 

Subject to clauses 6.2 and 6.3,
each time the Company proposes to issue any Company Shares on a date following the date on which the Tranche 6 Subscription
Amount has been received by the Company, the Company shall first offer (the Treasury Offer) such Company Shares to the Investor
on the following terms:

 

		(a)	The number of Company Shares the Investor shall be offered and may purchase shall
be equal to the total number of Company Shares being offered pursuant to the Treasury Offer (the Offered Shares).

 

		(b)	Each Treasury Offer shall be made by
written notice (an Offer Notice) to the Investor specifying (A) the total number and class of Offered Shares and (B) the price
and terms upon which the Company proposes to offer the Offered Shares.

 

		(c)	The Investor shall have 10 days (the Acceptance Period) following receipt
of the Offer Notice to accept the Treasury Offer. Acceptance of a Treasury Offer shall be made by
notice in writing (an Exercise Notice) to the Company within the Acceptance Period specifying that the Investor accepts
the Treasury Offer and wishes to purchase all, but not less than all, of the Offered Shares, at
the price and on the terms set out in the Offer Notice. An Exercise Notice shall be irrevocable and unconditional. If the Investor does not accept the Treasury Offer before expiration of the Acceptance Period, then the Investor shall be deemed to have refused the Treasury Offer.

 

    13

     

    

 

		(d)	If the Investor accepts the Treasury Offer in accordance with clause (c) above,
the closing of the purchase and sale of the Offered Shares shall occur within 20 days of the date of the Exercise Notice, and the Investor
shall pay the aggregate purchase price for the Offered Shares to the Company (or as the Company otherwise directs) by wire transfer in
immediately available funds. If the closing does not occur within such 20 day period, the Company shall be entitled to offer and sell
the Offered Shares to any other person in accordance with clause (e) below.

 

		(e)	If the Investor does not accept the Treasury Offer in accordance with the foregoing,
the Company shall be entitled to offer and sell the Offered Shares to any other person (a Third Party), provided that such sale
shall not be effected at an effective price which is less than the price set forth in the Treasury Offer. For greater certainty, where
the consideration to be received by the Company in connection with any proposed sale to a Third Party includes shares in the capital of
such Third Party, the effective price of the Offered Shares shall be equal to the sum of any cash consideration and the fair market value
of the shares of the Third Party to be received as consideration for the Offered Shares.

 

	6.2	Permitted Offering

 

The Company may issue Company Shares without complying
with clause 6.1 in the following circumstances only:

 

		(a)	Company Shares, or options exercisable
for Company Shares, issued or issuable to employees, officers, directors or consultants of the Company under any share option plan, employment
agreement or consulting agreement, each on terms approved by the board of directors of the Company, provided that any such issuances of
Company Shares shall be issued out of the
Company’s
ESOP pool of 3,225,000
Series A Common Shares;

 

		(b)	any subdivision of Company Shares (by a split of any Company Shares or otherwise),
payment of share dividend, reclassification, reorganization or any similar recapitalization;
provided that AHI is not disproportionately affected relative to the other shareholders by any such subdivision of Company Shares, payment
of share dividend, reclassification, reorganization or recapitalization; or

 

		(c)	Company Shares issued or issuable upon the exercise, conversion or exchange, in
accordance with their terms, of options or convertible securities that are on issue on the date of this Agreement.

 

	6.3	Termination of Right of First Offer

 

Unless otherwise provided below, the right of first offer
set out in clause 6.1 shall terminate automatically and without further act or formality on the earliest of:

 

		(a)	the occurrence of a Change of Control of the Company or the Investor;

 

    14

     

    

 

		(b)	a material breach by the Investor of any term of this Agreement or of any other
agreement entered into between the Investor and the Company, unless the Company otherwise determines in its sole and absolute discretion;

 

		(c)	the occurrence of an Event of Default in respect of the Investor, unless the Company
otherwise determines in its discretion;

 

		(d)	the date the Investor holds less than 50%
of the Company Shares issued to it pursuant to this Agreement; and

 

		(e)	the termination of this Agreement for any reason.

 

 

	7.	UNDERTAKINGS BY THE COMPANY

 

	7.1	Company Undertakings

 

The Company undertakes
to the Investor to:

 

		(a)	maintain its status as a corporation validly existing and in good standing under
the laws of the jurisdiction in which it is incorporated; and

 

		(b)	notify the Investor immediately if
any representation or warranty made by the Company in clauses 5.1 or 5.3 is found to be incorrect or misleading when made.

 

	7.2	Investor Undertakings

 

The Investor undertakes
to the Company to:

 

		(a)	maintain its status as a corporation validly existing and in good standing under
the laws of the jurisdiction in which it is incorporated; and

 

		(b)	notify the Company immediately if any representation or warranty made by
the Investor in clauses 5.1 or 5.2 is found to be incorrect or misleading when made.

 

 

	8.	DEFAULT

 

	8.1	Event of Default

 

It is an Event of Default if, whether or not it is within
the control of the Investor or the Company, as applicable (the Defaulting Party):

 

		(a)	non-remediable failure: the Defaulting Party fails to perform or observe
any material undertaking, obligation or agreement set out in this Agreement, including any obligation to pay an amount or issue shares
due to the other party (the Non-Defaulting Party) when due (other than, for certainty,
any failure to issue shares arising pursuant to Section 2.4), and that failure is not, in the reasonable opinion of the Non-Defaulting
Party, remediable;

 

		(b)	remediable failure: the failure described in clause 8.1(a) is, in the reasonable
opinion of the Non-Defaulting Party, remediable, and the Defaulting Party does not remedy the failure within 10 days, or a longer period
determined by the Non-Defaulting Party, after receipt by the Defaulting Party of a notice from the Non-Defaulting Party
specifying the failure;

    15

     

    

 

		(c)	misrepresentation: any warranty, representation or statement made by the
Defaulting Party hereunder is or becomes false, misleading or incorrect in any material respect when made;

 

		(d)	receiver: a receiver, receiver and manager, official manager, trustee, administrator
or similar official is appointed over the assets of the Defaulting Party and such appointment is not revoked or withdrawn within 30 days
of the appointment;

 

		(e)	insolvency: the Defaulting Party is or becomes unable to pay its debts when
they are due;

 

		(f)	arrangements: the Defaulting Party enters into or resolves to enter into
any arrangement, composition or compromise with, or assignment for the benefit of, its creditors or any class of them otherwise than while
solvent;

 

		(g)	winding up: an application or order is made for the winding-up or dissolution
of the Defaulting Party or a resolution is passed, or any steps are taken to pass a resolution for the winding-up or dissolution of the
Defaulting Party otherwise than for the purpose of an amalgamation or restructuring;

 

		(h)	de-listing:
the Investor’s
shares are
de-listed
from or suspended
from
trading on, any stock exchange, including the NASDAQ (other than any de-listing of shares of the Investor from the ASX in connection with
the acquisition of the Investor by AHI USA);

 

		(i)	de-registration: a notice under section 601AB of the Corporations Act is
given to, or an application under section 601AA is made by, or in respect of, the Investor;

 

		(j)	judgment: a judgment in an amount exceeding $500,000 is obtained against
the Defaulting Party and is not set aside or satisfied within 7 days; and

 

		(k)	execution: any distress, attachment, execution or other process of a government
agency in an amount exceeding $500,000 is issued against, levied or enforced upon any of the assets of the Defaulting Party.

 

		8.2	Non-Defaulting Party’s Powers on an Event of Default

 

The Defaulting Party shall promptly
notify the Non-Defaulting Party of the occurrence of an Event of Default in respect of the Defaulting Party. If an Event of
Default occurs, the Non-Defaulting Party may, at any time within 90 days of the date it has actual notice of the Event of Default,
terminate this Agreement by written notice to the Defaulting Party.

 

 

		9.	CONFIDENTIALITY

 

		9.1	Confidential Information

 

Each party is to keep
confidential the content and existence of this Agreement and any other information obtained from each other during the negotiations
preceding the execution of this Agreement or in the course of furthering the transactions contemplated by this Agreement whether in
the course of conducting due diligence or otherwise (Confidential Information), and is not to use it for any purpose other
than for the purpose of furthering the transactions contemplated by this Agreement nor disclose it to any person except:

 

		(a)	to employees, shareholders, legal advisers, auditors and other consultants who have
a need to know such information for the purpose of furthering the transactions contemplated by this Agreement and who have an obligation
of confidentiality in respect of such information at least equal to or better than the obligations of the parties hereunder;

 

		(b)	with the consent of the party which owns the Confidential Information or to which
the Confidential Information relates;

 

		(c)	if the information is, at the date of this Agreement, lawfully in the possession
of the recipient of the information through sources other than the other party and the recipient has made inquiry reasonable in the circumstances
to satisfy itself that such sources, at the time of their disclosure of such information to the recipient, were not prohibited from making
such disclosure by a confidentiality obligation, whether contractual, fiduciary or otherwise, owed to the other party or its affiliates;

 

		(d)	if required by a regulatory agency, court or a stock exchange rule, provided that
prior to such required disclosure (to the extent legally permissible) the recipient shall give the other party reasonable advance notice
of such a requirement to enable the other party to seek a protective order or other appropriate remedy;

 

		(e)	if strictly and necessarily required in connection with legal proceedings relating
to this Agreement;

 

		(f)	if the information is generally and
publicly available other than as a result of a breach of confidence or disclosure in violation of this Agreement; or

 

		(g)	to a financier, prospective financier or prospective acquirer (or their advisers)
of a party, provided that such party shall advise such financier, prospective financier or prospective acquirer (and their advisers) that
such information is confidential and require that such financier, prospective financier or prospective acquirer (and their advisers) abide
by the confidentiality obligations in this Agreement as if such person were a party hereto.

 

		9.2	Reasonable endeavours

 

A party disclosing Confidential
Information must use all reasonable endeavours to ensure that persons receiving the Confidential Information from it do not disclose or
use the Confidential Information except in the circumstances permitted in this Article 9. A party
disclosing Confidential Information shall be responsible for any disclosure or use of Confidential Information by its employees,
shareholders, legal advisers, auditors and other consultants in contravention of this Agreement and the other party will not be required
to first assert a claim against any of such persons as a condition of seeking or obtaining a remedy against the disclosing party.

 

    16

     

    

 

		9.3	Survival on termination

 

The
obligations under this clause 9 contain obligations separate and independent from the other obligations of the parties and remain
in existence for a period of five years from the date of this Agreement, regardless of any termination of this Agreement.

 

 

		10.	NOTICES

 

		10.1	Form of notice

 

A notice:

 

		(a)	must be in the English language; and

 

		(b)	may be given on behalf of a person by a solicitor, director, officer or company
secretary of the person.

 

		10.2	Means of giving notices

 

A notice may be given to the addressee
by:

 

		(a)	delivering it in writing to the street address of the addressee which includes placing
it in a postal receptacle provided for the address or leaving it at the address with a person apparently of or over the age of 16 years;

 

		(b)	sending it by registered mail (charges prepaid) to the street address of the addressee;
or

 

		(c)	sending it by email to the email address of the addressee.

 

		10.3	Specified address for service

 

		(a)	Until the Company gives notice of
a change, its street address and email address is:

 

		Address:	1 Adelaide Street East, Suite 3001 Toronto, Ontario M5C 2V9, Canada

 

	 	Email:	tory@triage.com

 

	 	Attention:	Tory Jarmain

 

		(b)	Until the Investor gives notice of a change, its street address and email address
is:

 

		Address:	Suite 5, 71-73 South Perth Esplanade, South Perth WA 6151 Australia

 

	 	Email:	vlado@advancedhumanimaging.com

 

	 	Attention:	Vlado Bosanac

 

    17

     

    

 

		10.4	Change of Address

 

A party may from time to time
change its address by giving notice pursuant to clause 10.1 to the other party.

 

		10.5	Receipt of notices

 

Any notice given pursuant to
clause 10.1 will be conclusively deemed to have been received:

 

		(a)	in the case of personal delivery, on the actual day of delivery if delivered prior
to 5 pm (in the recipient’s local time) on a Business Day or on the next following
Business Day if delivered
after 5 pm (in
the recipient’s
local time) on a Business Day or on a day other
than a Business Day;

 

		(b)	if sent by mail, on the second Business Day after the day of posting; or

 

		(c)	if sent by email, on the day the email was sent if sent prior to 5 pm (in the recipient’s
local time) on a Business Day or on the next following Business Day if delivered after 5 pm (in the recipient’s local time) on a
Business Day or on a day other than a Business Day.

 

 

		11.	NOVATION

 

		11.1	AHI USA

 

The parties acknowledge and agree
that, on the Novation Date, AHI USA will replace the Investor in all its capacities under this Agreement, will be deemed to have made
all of the representations and warranties of the Investor under this Agreement and will assume all of the Investor’s obligations
and liabilities under this Agreement, both those arising on or before the Novation Date and those arising thereafter. In addition, on
or prior to the Novation Date, the Investor shall cause AHI USA to (a) make any additional representations and warranties to the Company
that the Company reasonably determines are required in order to confirm
AHI USA’s
suitability
to subscribe
for Company
Shares under
applicable securities
laws
and (b)
execute a joinder
to the shareholders’
agreement
of the Company in effect at such time. The Investor will cause AHI USA to execute any other
documents (in a form reasonably acceptable to the Company) and do all other acts and things reasonably requested by the Company to give
effect to the foregoing as of the Novation Date. In furtherance of the foregoing, the Investor, AHI USA and the Company shall enter into
an assignment and assumption agreement on the Novation Date substantially in the form of the agreement attached as Schedule B hereto.

 

		11.2	References

 

On and from the Novation Date
but subject to compliance with clause 11.1, each reference in this Agreement to the Investor shall be deemed to be a reference to AHI
USA.

 

		11.3	Release by the Company

 

On and from the Novation Date
but subject to compliance with clause 11.1, the Company releases the Investor from:

 

		(a)	any obligation and liability under or in respect of this Agreement; and

 

    18

     

    

 

		(b)	any Claim which it may have or but for this release might have had against the Investor connected with
this Agreement.

 

		11.4	Release by the Investor

 

On and from the Novation Date
but subject to compliance with clause 11.1, the Investor releases the Company from:

 

		(a)	any obligations and liability under or in respect of this Agreement; and

 

		(b)	any Claim which it may have or but for this release might have had against the Company connected with
this Agreement.

 

 

		12.	MISCELLANEOUS

 

		12.1	Termination

 

Unless earlier terminated in accordance
with clause 8.2, this Agreement shall terminate (a) on the written agreement of the parties once all obligations under this Agreement
have been satisfied, or (b) automatically upon a Change of Control of the Company.

 

		12.2	Effect of Termination

 

On such termination, (a) subject
to (b) below, any amounts or share issuances due from the Defaulting Party to the Non-Defaulting Party accrued to the date of termination
shall be immediately due and payable or issuable, as applicable, and

(b) the Company is not obligated
to accept any further subscription from the Investor, or to issue any Subscription Shares after the date of such Event of Default.

 

		12.3	Amendments and Waivers

 

No amendment or waiver of any
provision of this Agreement shall be binding on either party unless consented to in writing by such party. No waiver of any provision
of this Agreement shall constitute a waiver of any other provision, nor shall any waiver of any
provision of this Agreement constitute a continuing waiver unless otherwise expressly provided.

 

		12.4	Taxes and withholdings

 

The Investor must make any payments
to be made to the Company free of all withholdings and deductions. For greater certainty, in the event that the Investor is required under
applicable law to withhold or deduct an amount from a payment to be made to the Company, the payment to the Company shall be increased
to the extent necessary to ensure that the Company receives a sum net of any withholding or deduction equal to the amount which it would
have received had no such withholding or deduction been made.

 

		12.5	Further assurance

 

Each party shall sign, execute
and do all deeds, acts, documents and things as may reasonably be required by the other party to effectively carry out and give effect
to the terms and intentions of this Agreement.

 

    19

     

    

 

		12.6	Governing law

 

This Agreement shall be interpreted
and enforced in accordance with, and the respective rights and obligations of the parties shall be governed by, the laws of the Province
of Ontario and the federal laws of Canada applicable in that province and each party irrevocably and unconditionally (a) submits to the
exclusive jurisdiction of the courts of the Province of Ontario over any action or proceeding arising out of or relating to this Agreement,
(b) agrees to commence such an action or proceeding in Toronto, Ontario, and to cooperate and use its commercially reasonable efforts
to bring the action or proceeding before the Ontario Superior Court of Justice (Commercial List),
(c) waives any objection that it might otherwise be entitled to assert to the jurisdiction of such courts and (d) agrees not to
assert that such courts are not a convenient forum for the determination of any such action or proceeding.

 

		12.7	Costs

 

Each party shall bear its own
legal costs of and incidental to the preparation, negotiation and execution of this Agreement.

 

		12.8	Severance

 

If any provision of this Agreement
is invalid and not enforceable in accordance with its terms, all other provisions which are self-sustaining and capable of separate enforcement
without regard to the invalid provision, shall be and continue to be valid and forceful in accordance with their terms.

 

		12.9	Entire Agreement

 

This Agreement, together with
(a) the shareholders’ agreement in respect of the Company to be entered into by the Investor, (b) the confidentiality agreement
dated December 11, 2020 entered into between the Company and the Investor and (c) the Reseller Agreement, shall constitute the sole understanding
of the parties with respect to the subject matter hereof and replaces all other agreements with respect thereto.

 

		12.10	Conflicts

 

In the event of any conflict
or inconsistency between the provisions of this Agreement
and the shareholders’
agreement
of the Company
to which
the Investor is a party, the shareholders’ agreement shall prevail with respect to the
Investor.

 

		12.11	Counterparts

 

This Agreement may be executed
in any number of counterparts (including by way of facsimile or other electronic means) each of which shall be deemed for all purposes
to be an original and all such counterparts taken together shall be deemed to constitute one and the same instrument.

 

    20

     

    

 

EXECUTED by the parties as of the date first written
above.

 

	EXECUTED by ADVANCED HUMAN IMAGING	 	)
	LIMITED	 	)
	ACN 602 111 115	 	)
	in accordance with section 127 of the Corporations Act 2001 (Cth):  	 	)
		 	 
	
	 	 
	Signature of authorized signatory	 	Signature of authorized signatory
	 	 	 
	 	 	 
	Vlado Bosanac	 	Steven Richards  
	Name of authorized signatory	 	Name of authorized signatory
	 	 	 
	EXECUTED BY	 	)
	TRIAGE TECHNOLOGIES INC.	 	)
	 	 	)
	 	 	)
	 	 	 
	 	 	 
	Signature of authorized signatory	 	Signature of authorized signatory
	 	 	 
	Tory Jarmain  	 	Eric Lau  
	Signature of authorized signatory	 	Signature of authorized signatory
	 	 	 

 

    21

     

    

 

 

SC HE DUL E A

 

 

Shareholders’ Agreement

 

(see attached)

 

    22

     

    

 

 

SC HE DUL E B

 

 

Assignment
and Assumption of the Subscription Agreement

 

THIS AGREEMENT is made the ■ day of ■, 2021

AMONG:

 

ADVANCED
HUMAN IMAGING LIMITED (ACN 602 111 115) of Suite 5, 71-73 South Perth Esplanade, South Perth WA 6151 Australia
(Investor)

 

		-	and -

 

[AHI USA] (a company incorporated under the laws of
■) of [address] (AHI USA)

 

		-	and -

 

TRIAGE TECHNOLOGIES INC. (a company incorporated
under the federal laws of Canada) of 1 Adelaide Street East, Suite 3001 Toronto, Ontario M5C 2V9 Canada (Company);

 

WHEREAS
the Investor entered into a subscription agreement (the Subscription Agreement) with Triage Technologies Inc. (the Company)
on March 31, 2021 pursuant to which the Investor irrevocably agreed to, among other things, subscribe for 4,466,748 Subscription Shares
for the Aggregate Subscription Price;

 

AND WHEREAS the Novation Date has occurred as of
the date hereof;

 

AND WHEREAS,
in accordance with the Subscription Agreement, the Investor wishes to transfer, assign, convey and set over to AHI USA, and AHI USA wishes
to accept the conveyance of, all of the Investor’s obligations and liabilities under the Subscription Agreement;

 

NOW THEREFORE
in consideration of the mutual covenants and agreements hereinafter contained and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereby covenant and agree as follows:

 

		1.	Definitions and Interpretation

 

		(a)	Unless otherwise defined herein, all capitalized terms used in this Agreement, including
in the recitals hereto, shall have the respective meanings ascribed to them in the Subscription Agreement.

 

		(b)	This Agreement shall be construed in accordance with the rules of interpretation
in Section 1.2 of the Subscription Agreement.

 

		2.	Assignment and Assumption

 

		(a)	The Investor hereby transfers, assigns, conveys and sets over to AHI USA its entire
right, title and interest in the Subscription Agreement. AHI USA hereby accepts and assumes the transfer, assignment and conveyance from
the Investor of its entire right, title and interest in the Subscription Agreement.

 

		(b)	The Investor hereby assigns and transfers to AHI USA, and AHI USA hereby accepts
and assumes, all liabilities of the Investor associated with the
Subscription Agreement and agrees to pay, keep, observe and perform all of the terms, covenants, conditions and obligations of the Investor under the Subscription Agreement.
 

 

    23

     

    

 

		3.	Representations and Warranties

 

AHI USA represents and warrants to the Company, as an inducement
to the Company entering into the Agreement that:

 

		(a)	each of the representations and warranties of the Investor in Sections 5.1 and 5.2
of the Subscription Agreement are true and correct as of the date hereof as if such representations and warranties were made by AHI USA,
except the representations and warranties in Sections 5.2(a), 5.2(b) and 5.2(d) of the Subscription Agreement;

 

		(b)	its decision to enter into this Agreement and subscribe for the Subscription Shares
was made in the United States of America; and

 

		(c)	it is a person to whom it is lawful to offer or issue the Subscription Shares without
a disclosure document and it is an “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) of Regulation
D, promulgated by the Securities and Exchange Commission under Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder.

 

		4.	Joinder

 

AHI USA shall execute a joinder
to the shareholders’ agreement of the Company in effect on the date hereof and deliver same to the Company on the date hereof.

 

		5.	Further Assurances

 

The Investor and AHI USA shall
execute and deliver such additional documents and instruments and shall perform such additional
acts as may be necessary or appropriate in connection with this Agreement and all transactions contemplated by this Agreement to effectuate,
carry out and perform all of the covenants, obligations and agreements of this Agreement and such transactions.

 

		6.	Governing Law

 

This Agreement shall be interpreted
and enforced in accordance with, and the respective rights and obligations of the parties shall be governed by, the laws of the Province
of Ontario and the federal laws of Canada applicable in that province and each party irrevocably
and unconditionally (a) submits to the exclusive jurisdiction of the courts of the Province of Ontario over any action or proceeding
arising out of or relating to this Agreement, (b) agrees to commence such an action or proceeding in Toronto, Ontario, and to cooperate
and use its commercially reasonable efforts to bring the action or proceeding before the Ontario Superior Court of Justice (Commercial
List), (c) waives any objection that it might otherwise be entitled to assert to the jurisdiction of such courts and

(d) agrees not to assert that such
courts are not a convenient forum for the determination of any such action or proceeding.

 

		7.	Counterparts

 

This Agreement may be executed
in any number of counterparts (including by way of facsimile or other electronic means) each of which shall be deemed for all purposes
to be an original and all such counterparts taken together shall be deemed to constitute one and the same instrument.

 

    24

     

    

 

EXECUTED
by the parties as of the date first written above.

 

	EXECUTED by AHI USA	 	)
	 	 	)
	 	 	)
	 	 	)
	 	 	 
	 	 	 
	 	 	 
	Signature of authorized signatory	 	Signature of authorized signatory
	 	 	 
	 	 	 
	Name of authorized signatory	 	Name of authorized signatory  
	 	 	 
	 	 	)
	EXECUTED by ADVANCED HUMAN IMAGING	 	)
	LIMITED	 	)
	ACN 602 111 115	 	)
	in accordance with section 127 of the Corporations Act 2001 (Cth):	 	 
	 	 	 
	 	 	 
	Signature of authorized signatory	 	Signature of authorized signatory
	 	 	 
	 	 	 
	 	 	 
	Name of authorized signatory	 	Name of authorized signatory
	 	 	 
	 	 	 
	EXECUTED BY	 	)
	TRIAGE TECHNOLOGIES INC.	 	)
	 	 	)
	 	 	)
	 	 	 
	 	 	 
	Signature of authorized signatory	 	Signature of authorized signatory
	 	 	 
	 	 	 
	 	 	 
	Name of authorized signatory	 	Name of authorized signatory

 

 

25

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]